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Abstract
This work presents Boxed Molecular Dynamics (BXD), an
efficient simulation tool for studying long time scale pro-
cesses which are inaccessible to conventional methods of sim-
ulation. Boxed Molecular Dynamics is explained and intro-
duced in the context of modelling the dynamics of proteins
and peptides. Two major applications of Boxed Molecular
Dynamics are reported.
1) - The mechanical unfolding of proteins induced by Atomic
Force Microscopy methods is investigated. For the first time,
experimental data is reproduced and unfolding pathways are
investigated without the use of high artificial pulling forces
which makes the simulation less realistic.
2) - A cheap and accurate in silico screening tool is devel-
oped to aid with the discovery and production of medicinal
cyclic peptides. Enzymatic peptide cyclization is investi-
gated by BXD and the ability of amino acid sequences to
cyclize is predicted with an accuracy of 76 %.
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Proteins are large biopolymers which perform a vast array of tasks in
living organisms. Examples include forming structures, catalysing reac-
tions, DNA replication, molecule and ion transport as well as enabling
movement.1 Proteins are made up of chains of amino acids linked to-
gether. There are 20 naturally occurring amino acids all sharing a com-
mon structure of a central carbon atom flanked by COOH and NH2
groups. The general structure of an amino acid is shown in figure 1.1.
Figure 1.1: general structure of an amino acid. Note the left handed stere-
ochemistry which is present in all naturally occurring amino acids.
Amino acids differ in the identity of the R group known as the
side chain, which defines the property of the amino acid. The twenty
natural amino acids are shown in figure 1.2 and can be divided into
those with polar, non-polar and ionic side chains. Amino acids with
polar or ionic side chains are hydrophillic and are generally found on
the outside of a protein where they can interact with water. Ionic side
1
1.1 Proteins
chains often form salt bridges where a cationic side chain interacts with
an anionic side chain, stabilising the structure of the protein. Amino
acids with non-polar side chains are hydrophobic and are usually found
in the water free core of a protein. These competing effects underly
many of the structural and functional properties of proteins and other
biomolecular machinary.2
Figure 1.2: the 20 naturally occurring amino acids which can be classified
according to the nature of their side chains.
The ribosome is a structure in the cell which builds up a chain of
2
1.1 Proteins
amino acids into a protein one link at a time. Amino acids join together
via the condensation reaction shown in figure 1.3.
Figure 1.3: amino acids form a chain via the condensation reaction to build
up a protein.
Once incorporated into a protein chain the amino acids are known
as residues as some of the original atoms are lost in the condensation re-
action. The chain of carbon and nitrogen atoms which has been formed
is known as the backbone. The smallest proteins known as peptides
have less than ten residues while the largest discovered, titin, has around
34000 which equates to over half a million atoms.
Protein structure exists on four levels. Primary structure is the
sequence of residues forming the chain. Secondary structure is the local
three dimensional form of the chain, held in place by the hydrogen
bonding between carbonyl oxygens and amide hydrogens on the protein
backbone. The two forms of secondary structure found in nature are
3
1.1 Proteins
alpha helices and beta sheets, shown in figure 1.4. In an alpha helix
the backbone forms a right handed helix with the side chains radiating
outwards. In a beta sheet the backbone is layered into parallel strands
while the side chains stick out to the sides. Alpha helices and beta
sheets are joined by short unstructured sections of chain known as turns
or links.
Figure 1.4: a section of alpha helix (top) and beta sheet (bottom). The
peptide backbone is shown by the ribbon and the hydrogen bonds, which
stabilize the secondary structure are shown by the dashed lines.
Tertiary structure is the arrangement of secondary structure into
independent units known as a domains. Unlike secondary structure,
which is fixed by hydrogen bonds between backbone atoms, tertiary
structure is also determined by interactions between the side chains. As
there are 20 amino acids there is a very large number of possible inter-
actions and hence a wide range of possible tertiary structures. Water
plays a role in tertiary structure formation; in many proteins the hy-
drophobic side chains are placed in the water free core of the protein
while hydrophilic side chains are exposed to the solvent. A selection of
domains is shown below in figure 1.5.
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Figure 1.5: A selection of protein domains showing different tertiary struc-
tures which are classified as all alpha, all beta, alpha/beta (alternating sec-
tions of alpha helix and beta sheet) and alpha+beta (segregated alpha he-
lixes and beta sheets). Alpha helixes are shown in red, beta sheets in blue
and the flexible linkers between units of secondary structure are shown in
grey. These structures were chosen to show a broad spectrum of the types
of secondary structure and their combinations. Structures were downloaded
in pdb form from the RCSB databank: 1IMQ (all alpha), 1TIT (all beta),
2ZFL(alpha/beta) and 3BGM (alpha + beta).
Quaternary structure is the highest level of structure and is defined
as the arrangement of multiple folded subunits relative to each other.
Each folded subunit is a seperate chain of amino acids with distinct
tertiary structure. As such a quaternary protein is not a single covalent
molecule but a complex of several smaller units. An example of a protein
showing quaternary structure is shown below in figure 1.6.
5
1.1 Proteins
Figure 1.6: a protein showing quaternary structure: the arrangement of
folded subunits, shown by different colours, relative to each other. The pro-
tein shown is an E. coli class Ia ribonucleotide reductase, the structure was
downloaded from the RCSB databank (5CNU) and was chosen because it
shows a high level structure which is clearly made up of independant folded
subunits.
Many proteins show a very high degree of conformational flexibility
and do not exhibit any stable structure. Known as intrinsically disor-
dered proteins, these species can form indepentent subunits or occur as
flexible linkers between stable protein domains in larger structures.3
Protein function is crucial to countless biological processes and un-
derstanding it is vital to treating and curing most diseases and condi-
tions. Function comes from structure and dynamics; proteins move and
change conformation at room temperature and form labile complexes
with other proteins and smaller molecules. These processes are hard
to observe in experiment4–6 so some form of simulation is necessary to





Since the first Molecular Dynamics study in 19577 MD simulation has
become a useful tool for the advancement of chemical and biological
understanding.4 MD allows the elucidation of many structures and pro-
cesses that cannot be directly observed by experiment4–6 and is becom-
ing increasingly popular in the study of biological systems since it was
first used to study protein structure in 1976.8 Aspects of biology ex-
plored by MD include enzyme catalysis,9 protein folding,10–14 ion and
small molecule transport15;16 and ligand binding.17
MD is used to observe dynamic processes of biomolecules such as
conformational change, or to calculate properties such as structure. The
property or process under investigation is modelled as a function of the
position and velocity of each atom in the system. Biomolecules undergo
significant structural fluctuation at room temperature and a simulation
needs to be time resolved to capture this. For example, to find the
structure of a protein, the positions of the atoms are calculated over a
period of time and averaged, as the structure is not fixed and will vary
with the dynamics of the system. This differs from a small molecule
quantum mechanical calculation where a structure is obtained from a
simple potential energy minimisation.
To simulate the time evolution of a molecule (known as a trajec-
tory) it is necessary to model the interactions between the atoms. MD
defines these interactions classically, for example covalent bonds are
treated as simple harmonic oscillators while non-covalent interactions
are modelled with simple electrostatic and Lennard-Jones potentials.
This is done in order to reduce the cost of the calculation; there are
too many atoms in biomolecules for electrons to be explicitly included.
Each atom is described by a set of parameters such as covalent bond
force constants and Lennard-Jones constants. The parameters used to
calculate the potential energy, known as a force-field, differ between
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models.
Knowing the potential energy, the position and velocity of each
atom can be calculated and propagated forwards in time. This is done
by applying Newtonian mechanics to each atom using a finite difference
method where dynamics are calculated over a series of discrete time
steps rather than on a continuous scale in order to make the computation
less expensive. MD simulations use numerous finite difference methods,
or integrators, to calculate a trajectory. The primary integrator used in
this work is the Leapfrog integrator.18
1.3 The Long Timescale Problem
The idea of inputing a set of atomic coordinates into a computer and
watching a protein fold, or an enzyme catalyse a reaction, sounds too
good to be true. Indeed, MD faces a major problem with the timescales
involved in most biological processes. This is demonstrated by the ex-
ample of protein folding - given a sequence of amino acids, what is
the lowest free energy structure? In theory this would be answered by
starting an MD simulation with a chain of amino acids and watching the
trajectory take the molecule into its the lowest free energy conforma-
tion. The quantity calculated here would be the average position of the
atoms in the conformation corresponding to the native structure. This
is unlikely to be found by MD as proteins fold on a timescale of mil-
liseconds to seconds and sometimes even longer,19 while the time step
of an MD simulation is around one femtosecond. This would require
propagating the trajectory over a very large number of time steps.
This brute force structure calculation has been shown to be possible
in principle by the Shaw group, who used a specially built supercom-
puter to fold a number of proteins using MD simulations.20–22 Despite
the promise of these simulations, the problem of long time scales re-
mains as the force fields used in MD simulations are parameterised by
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reproducing physical quantities of liquids, such as density, from short
timescale simulations. It has been shown that these force fields do not
remain fully valid when extended over the much longer timescales of
protein folding.23
The long timescales arise from the fact that the free energy land-
scape of a protein is very complicated, featuring many wells and barriers
with meta-stable states and kinetic traps. This makes the conformation
space hard to explore in sufficient detail in a reasonable amount of time.
Given a one dimensional reaction coordinate x which describes a
process such as protein folding, the probability of x having a particular
value is related to the corresponding free energy and the temperature
in the following way:
P (x) = e
−G(x)
kBT (1.1)
It is clear from equation 1.1 that areas of high free energy will
rarely be sampled because of the vanishingly small probability of the
trajectory arriving there. This means that the trajectory will move
downhill into whatever free energy well it finds first and stay there as
the barriers around the well are too high to be crossed in a timescale
accessible to simulation. Convergence will be poor as few regions of the
conformational space have been sampled. This problem, common to
many biological processes, is illustrated below in figure 1.7.
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Figure 1.7: in the ideal simulation the trajectory takes the molecule into
its lowest free energy conformation. In reality the free energy landscape is
complex, featuring many local minima with barriers between them. The
trajectory finds a minimum and stays there. The simulator cannot know
whether this is a local or a global minimum as only a small fraction of the
conformation space will have been sampled.
1.4 Long Timescale Methods
Numerous methods exist which deal with this problem. Known as ac-
celerated sampling methods, these techniques usually fall into one of
three categories: biasing methods, reactive flux methods and tempera-
ture methods. In this section some of the more common techniques are
reviewed.
1.4.1 Biasing Methods
With these methods a reaction coordinate x is defined to describe the
process under investigation. The potential energy is modified so that
the trajectory moves along x more easily, crossing barriers that would
otherwise be too high for an unbiased trajectory to move over.
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Umbrella Sampling
Umbrella sampling24;25 modifies the potential energy function by adding
a bias which pushes the trajectory over barriers. The modified potential
U ′ (r) is obtained by adding a biasing term which is a function of the
position along the reaction coordinate:
U ′ (r) = U (r) +W (x) (1.2)
where U ′ (r) is the new potential energy function, U (r) is the original
potential and W (x) is the biasing potential along the reaction coordi-
nate, usually chosen to be a harmonic potential or umbrella:
W (x) = k (x− x0)2 (1.3)
where k is a constant and x0 is the centre of the umbrella. In practice
many simulations, with biasing potentials centred on different values of
x0, are combined. Between the set of simulations the reaction coordinate
is covered by umbrellas, allowing all barriers to be crossed. This is shown
in figure 1.8.
Figure 1.8: umbrella sampling places a series of harmonic biasing potentials
along the reaction coordinate.
The unbiased free energy is recovered via the Weighted Histogram
Analysis Method or WHAM26. From the whole set of simulations, the
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biased probability P ′i (x) of observing a state in which the reaction co-
ordinate has a value of x in simulation i is








where P (x) is the probability of the reaction coordinate having value x
with the unbiased free energy (see equation 1.1), Wi (x) is the biasing
potential used in simulation i and U (r) is the unbiased potential energy.
Recovering P (x) will allow the unbiased free energy along the reaction
coordinate to be obtained as, by rearranging equation 1.1,
∆G (x) = −kBT ln [P (x)] (1.5)
where ∆G (x) is the free energy a function of the reaction coordinate.
Computing P (x) is non trivial and convoluted.
A more advanced version of Umbrella Sampling is Adaptive Bias
Umbrella Sampling (27) where the biasing potential is expanded to cover
the whole reaction coordinate, and varied on the fly until the simulation
populates all states equally. At this point the combination of the free
energy and biasing potential results in a flat energy surface as all points
along the reaction coordinate are equally probable. The advantage of
this is that the free energy can be recovered as the negative of the biasing
potential rather than via more convoluted algorithms.
Metadynamics
Metadynamics fills in free energy wells to flatten out the energy land-
scape along the reaction coordinate.28 A biasing potential is constructed
by adding Gaussian potentials, until the well is filled up and then crosses
into the next well. This is then filled up and the process is repeated
until the free energy along the reaction coordinate is flat, allowing the
reaction coordinate to be well sampled. This is illustrated in figure 1.9.
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Figure 1.9: metadynamics fills up free energy wells with biasing potentials
(blue) and allows the trajectory (red) to travel easily along the reaction
coordinate.
As with adaptive bias umbrella sampling the biasing potential will
converge to the negative of the unbiased free energy along the reaction
coordinate.
In general, biasing methods quickly accelerate the sampling of a
reaction coordinate and allow the observation of many processes which
would be inaccessible to conventional MD. However, unbiasing the re-
sults to obtain equilibrium free energies and kinetics is often compli-
cated. Also for methods such as metadynamics, prior knowledge of the
free energy profile along the reaction coordinate is needed which limits
the number of applications.
1.4.2 Reactive Flux Methods
Reactive flux methods are based on Transition State Theory32;33 (TST)
in which the phase space is partitioned into two sections separating
states A and B with a dividing surface between them. The rate constant
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where x is the reaction coordinate describing the path from states A to
B, x∗ is value of x at which the dividing surface is located and W (x∗) is
the reversible work needed to move the system from state A to x∗. The
fraction represents the equilibrium probability of finding the system at
x∗ compared to the probability of being at A. The constant κ represents
the fraction of trajectories which, on reaching the transition state x∗,
cross over and reach state B.
Expressed informally, the TST equation states that the rate con-
stant for a transition from A to B is equal to the chance of finding
the system at the transition state, multiplied by the probability of the
trajectory then crossing over to state B and remaining there. Equation
1.6 forms the basis of reactive flux methods. The dividing surface x∗ is
formally the transition state between A and B however this does not
have to be the case; equation 1.6 is valid for arbitrary states A and B
which do not have to represent stable states. The position of the surface
x∗ can also be arbitrary.
In general these methods work by dividing up the phase space with
many such surfaces and calculating the rate constants between them.
A selection of reactive flux methods is reviewed below.
Milestoning
Milestoning29;30 places a series of planes or milestones in phase space
along a reaction coordinate. A set of conventional MD simulations are
initiated on and restricted to each plane, generating an ensemble of
conformations for each plane. Each of these conformations is then run
as a separate unbiased trajectory until it reaches the next plane, at
which point it is terminated. A trajectory initiated at plane Hn has a
lifetime τ+ if it ends at plane Hn+1, and τ
- if it ends at plane Hn−1.
This is shown below in figure 1.10.
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Figure 1.10: in milestoning planes are placed along a reaction coordinate
between reactants and products. Conformations are released from a plane
until they hit the next one and the time taken from release to collision is
recorded.
The distribution of trajectory lifetimes going from plane Hn to
Hn+1 is written as Kn
+ (τ), and as Kn
- (τ) for those going from plane
Hn to Hn−1. K0- and Km+ are zero as below plane H0 and above plane
Hm there are no other planes to hit. If the equilibrium probability
P eq (n) of a trajectory being found on milestone Hn were known then the
free energy along the reaction coordinate could be found from equation
1.5, as such a distribution would represent the probability of finding a
trajectory along the reaction coordinate. The probability of finding a












where the integrand is the probability of arriving at Hn at time t
′ and
not leaving before time t.
Kn (t− t′) is defined as Kn+ +Kn- and Qn (t′) is defined as
Qn (t
′) = 2δ (t)Pn (0) +
∫ t
0
Qn±1 (t′′)K±n±1 (t− t′′) dt′′. (1.8)
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Equation 1.8 is the probability of a transition to Hn expressed
as a sum over the initial conditions of the starting trajectories Pn (0),
and over previous transitions to Hn+1 followed by a transition to Hn.
Solving equations 1.7 and 1.8 gives the equilibrium probability of finding
a trajectory at Hn at time t:
P eq (n) = lim
t→∞
Pn (t) (1.9)
where limt→∞ Pn (t) is found by running the trajectories until the distri-
butions of lifetimes converges. Now the free energy along the reaction
coordinate is obtained from equation 1.5.
A recent modification31 of milestoning replaces the dividing sur-
faces with polygons rather than simple planes. The polygons, known as
Voronoi polyhedra, divide the phase space into a network of tessellating
cells. Trajectories are initiated in each cell and confined within it. The
frequency at which the trajectory hits a boundary between polyhedra
is used to calculate the rate constant for passage between them. In this
way the phase space can be sampled in multiple dimensions rather than
along a one dimensional reaction coordinate.
Forward Flux Sampling
In forward flux sampling35 (FFS) a series of planes (denoted λ0, λ1, ...λn)
are defined in the phase space between the product and reactant regions
(A and B). Trajectories are initiated on λ0 which lies on the initial state
A. If a trajectory reaches λ1 then its conformation is stored and used to
restart multiple trial trajectories. If a trial trajectory reaches the next
plane λ2 then it is counted as a success, and as a failure if it returns to
λ1. Successful trajectories are again stored and used as starting points
for a fresh set of trial trajectories until the final state B is reached. This
is illustrated below in figure 1.11.
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Figure 1.11: in forward flux sampling, planes are placed along the phase
space between initial state A and final state B. A trajectory is released from
plane λ0 at state A and the conformation is stored if it reaches the next plane
λ1. This stored conformation is used to seed multiple trial trajectories from
λ1. The ratio of successful trajectories that reach the next plane (red) to
trajectories which return to the previous plane (blue) is used to calculate the
probability of passage between planes. Once this is known for each plane the
free energy from states A to B can be calculated.
The ratio of successful to failed trajectories at plane λm gives the
probability of transition from λm to λm+1. Once this is known for all
the planes then the free energy for the entire process is obtained by
using equation 1.5. FFS has the added advantage that a sequence of
successful trial trajectories that make it all the way to state B can be
joined together to form an unbiased trajectory representing the overall
transition from A to B.
In addition to the two methods described above there are many
other reactive flux methods which work in a similar way. These in-
clude transition path sampling,36 transition interface sampling,37 the
weighted ensemble method38 and the finite temperature string method.39
These methods accelerate the rate of sampling because a trajectory must
only reach the next boundary. This allows energy barriers to be crossed
as the boundaries act as a ratchet, allowing the process to be simulated
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in a series of small hops rather than one large unlikely jump from A to B.
The advantage of these techniques is that no biasing of the poten-
tial energy is needed which simplifies the generation of equilibrium free
energies and kinetics. However these methods often require multiple
trajectories to be run at different points in the phase space, compli-
cating the procedure and requiring prior knowledge of the free energy
landscape.
One of the major limitations of both biasing and reactive flux meth-
ods is the need to define a reaction coordinate. This is often difficult
as the motion of biomolecules is highly dimensional, with many pro-
cesses requiring movement accross a large proportion of the 3N degrees
of freedom available to a molecule of N atoms. Because of this it can be
hard to find a one dimensional reaction coordinate which differentiates
between the states of the system and describes the pathways between
them.40
1.4.3 Temperature Methods
Temperature methods vary the temperature of the simulation in order
to push the trajectory over free energy barriers. The most basic of these
techniques is simulated annealing.
Simulated Annealing
In simulated annealing41 the temperature is raised which lifts the system
over free energy barriers. The temperature is then reduced so that the
molecule falls into an energy minimum and the process is repeated, ex-
ploring multiple minima which would not be accessed by a conventional
trajectory, see figure 1.12.
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Figure 1.12: simulated annealing heats and cools the system to explore
multiple energy minima.
Replica Exchange
Simulated annealing has developed into the replica exchange method42
where separate simulations are carried out at different temperatures.
These simulations, known as replicas, do not interact but can swap
temperatures with their neighbours. Because of this the trajectories
take a random walk in temperature space which allows them to cross
barriers easily and cool down into minima that would otherwise not be
sampled.
The advantage of temperature methods is that the phase space
can be efficiently sampled without modifying the potential energy or
dividing up the phase space with boundaries. This requires no prior
knowledge of the process under investigation. Also there is no need to
define a reaction coordinate to describe the process of interest, which
is a major limitation of many accelerated sampling methods as a suit-
able coordinate does not always exist. However, simulated annealing
does not allow equilibrium dynamics to be reconstructed and replica
exchange is a complicated process to implement as many trajectories
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must run in parallel and swap temperatures with each other.
Now that MD has been introduced along with a selection of acceler-




Boxed Molecular Dynamics (BXD) is a method of calculating the free
energy and kinetics of a slow process. It is a simple method which does
not require any modification of the potential energy or any prior knowl-
edge of the process under investigation. In this chapter the foundations
of BXD will be introduced along with the assumptions on which it relies
and the conditions under which these are valid.
2.1 Accelerated Classical Dynamics (AXD)
BXD is based on Transition State Theory32 and is similar to several re-
active flux methods. Boundaries are placed along a reaction coordinate
which partition the phase space into a series of boxes. The boundaries
are reflective and confine the trajectory within a box. This is done by
monitoring the value of the reaction coordinate as the simulation pro-
gresses. If the value crosses a threshold at which a boundary is located
then the velocities of the atoms are inverted with respect to the reaction
coordinate. This is illustrated in figure 2.1.
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Figure 2.1: the velocity of an atom is reflected with respect to the reaction
coordinate when a boundary is hit. If the velocity before the collision is v
with a component vparallel along the reaction coordinate then the velocity
after the reflection is given as v′ = v − 2vparallel.
To understand the link with TST consider a simple system of two
reflecting boundaries shown below in figure 2.2. This set-up is an early
version of BXD known as Accelerated Classical Dynamics (AXD).
Figure 2.2: the AXD set-up. Reflective boundaries lock the trajectory in
the region near the transition state. The accelerated rate constant kAXD is
quickly converged as the important region of phase space near the transition
state is well sampled.
One boundary is placed on the transition state while another is
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placed nearby on the reactants side, locking the trajectory in the area
of phase space Γ1. According to TST the reaction rate will be the
frequency at which a trajectory hits the boundary between Γ0 and
Γ1. TST assumes that trajectories cross the boundary at the transi-
tion state, while in BXD and AXD the trajectory is reflected from the
boundary. However these two cases are equivalent providing the boxes
are in equilibrium. This is because a reflected trajectory is the same
as a trajectory which leaves and is replaced by an incoming one on the
reflected path.43
By locking the trajectory in Γ1 the region around the transition
state is sampled more often leading to an accelerated rate constant
kAXD. This is related to the actual rate constant kTST in the following
way:
kTST = kAXDPCORR (2.1)
where kTST is the actual rate constant for the reaction, kAXD is the
accelerated rate and PCORR is a correction factor equal to the probability





which is the fraction of reactant phase space enclosed in region Γ1. Pcorr
can be reearanged into a function of the rate constants for diffusion












Equation 2.2 can be derived from the principles of TST, as the
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where kTST is the TST rate constant for diffusion from the reactant state
to product space, |µ| is the magnitude of the velocity vector normal to
the dividing surface in phase space, Θ(q, p) is a function of the position
q and momenta p of the system which is unity when the system is in the
reactant region R and zero otherwise, δ(q, p) is a Dirac delta function
which is unity at the dividing surface and ΓR is the phase space volume
of region R. As the reactant space is divided by a reflecting boundary











which gives equation 2.2, as the term 〈|µ|δ(q,p)Θ(q,p)〉
Γ1
is directly calculated
from AXD by locking the trajectory in Γ1. The rate constants k12
and k21 necessary to calculate PCORR can be obtained by locking the
trajectory in box Γ1+Γ2. The speed-up gained from AXD is due to the
fact that it is much faster to converge kAXD and PCORR separately than
it is to converge kTST . This is because an unconstrained trajectory
would rarely visit the region near the transition state if there was a
barrier between reactants and products.
2.2 Main Idea of BXD
BXD works in the same way as AXD but with multiple boundaries
placed along the whole reaction coordinate. The trajectory starts in a
box and after a certain number of collisions with the next boundary it
is allowed through into the next box. This process is then repeated and
the trajectory passes into the next box, and so on until the final box has
been reached and the direction is reversed. The location of the boxes
does not affect the result as TST is still valid if the boundary does not
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lie on a transition state.33
Placing these boundaries along the reaction coordinate allows free
energy barriers to be crossed quickly. This is due to the fact that, after
the trajectory enters a new box, it cannot go back into the previous
one. In this way the boxes act as a ratchet, preventing the trajectory
from rolling back downhill. This is illustrated in figure 2.3. When the
final box has been reached the direction of travel is reversed and the
process continues until the entire reaction coordinate has been sampled
multiple times in both directions.
Figure 2.3: reflecting boundaries (red lines) along the reaction coordinate
confine the trajectory (blue ball) into boxes allowing free energy barriers to
be crossed. The boxes act like a ratchet and stop the trajectory rolling back
downhill.
Figure 2.4 shows a plot of the reaction coordinate value against
time for a typical BXD simulation, illustrating how the trajectory moves
through the boxes.
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Figure 2.4: a plot of the reaction coordinate value against simulation time
from a BXD simulation shows how the trajectory (blue) moves through the
boxes and samples the phase space. The reflective boundaries are shown by
red lines.
In this way the entire reaction coordinate is scanned until the sam-
pling converges. Splitting the phase space into boxes not only allows
free energy barriers to be crossed, it also makes it possible to calculate
the rate constants and free energy along the reaction coordinate. This
is shown in figure 2.5.
Increasing the resolution in this way reveals many fine details of
the free enrgy landscape. These details are generally meaningful as the
uncertainty in the free energy, resulting from the distribution of first
passage times used to calculate the rate constant, is usually less than
one percent. This figure is very low because on each boundary there
are tpyically over 100000 first passage times. It should be noted that in
this work the free energies presented are the result of averaging 10 to
20 individual free energies and the uncertainty is calculated as the stan-
dard deviation of the set of free energies used to calculate the average.
This error is larger than the error coming from the distribution of first
passage times, which suggests that independent trajectories extensivly
sample slightly different pathways.
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Figure 2.5: illustration of BXD showing boundaries (ρm, ρm−1, ...ρ0) placed
along the reaction coordinate, dividing the phase space into boxes. The rate
constants between each box and its neighbours are quickly calculated and are
used to obtain the free energy along the reaction coordinate. Dotted lines
show smaller bins within the boxes which increase the resolution of the free
energy.
BXD is similar to umbrella sampling in that the trajectory is re-
stricted in various windows placed in phase space, however the main dif-
ference is that BXD uses a square well restraint rather than a harmonic
constraint, and BXD also provides simultaneous kinetics and thermo-
dynamics without the need for compliacted unbiasing routines.
While the trajectory is in box m the time between successive col-
lisions with the boundary ρm−1 is recorded. These times are referred to
as first passage times (FPTs). The set of FPTs for each boundary is




where km,m−1 is the rate constant for diffusion from box m into box
m − 1 and 〈τm,m−1〉 is the mean of the first passage times (MFPT)
on boundary ρm−1. Once the rate constant for diffusion in the opposite
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where Km,m−1 is the equilibrium constant for diffusion between boxes
m and m− 1. The free energy difference between boxes m and m− 1 is
simply
∆Gm,m−1 = −RT lnKm,m−1. (2.8)
In this way it is possible to obtain the free energy along the whole
reaction coordinate. It is also possible to calculate the probability of a
trajectory populating any box m as a function of time. For a series of
boxes the rate of change of the population of box m is
dnm (t)
dt
= km−1,mnm−1 (t)+km,+1,mnm+1−nm (km,m−1 + km,m+1) (2.9)
where nm (t) is the population in box m as a function of time. The
right hand side of equation 2.9 is the flux entering the box minus the
flux leaving. For a system of N boxes equation 2.9 can describe the
population of every box in matrix form:
dn (t)
dt
= Mn (t) (2.10)
where M is an N by N matrix of rate constants and n (t) is a vector
of length N of the populations of each box as a function of time. The
solution to equation 2.10 can be expressed through the eigenvalues and
eigenvectors of M as
n (t) = UeλtU−1n (0) (2.11)
where n (0) is a vector containing the initial population of each box
which is assigned from a Boltzmann distribution, U is the eigenvector
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matrix obtained by diagonalising M and λ is the vector of correspond-
ing eigenvalues. In general the eigenvalues are all negative and one will
be separated from the others by several orders of magnitude. If an irre-
versible reaction is being studied then the flux out of the products box
can be set to zero and the resulting lowest eigenvalue is taken to be the
rate constant for the reaction.
BXD has much in common with other reactive flux sampling meth-
ods such as milestoning and forward flux sampling. All three methods
place boundaries in phase space along a reaction coordinate, allowing
the barriers to be crossed while calculating the free energy along the
coordinate. However, BXD has the advantage of yielding kinetic and
thermodynamic information simultaneously. BXD is also a very simple
technique; a single trajectory can be left alone by the user to sample
the reaction coordinate. In milestoning, multiple trajectories need to be
initiated in different boxes which is more complicated and also requires
prior knowledge of the conformational space. In forward flux sampling
trajectories must be stored at various points and used to start a new
batch of trial runs.
2.3 High Resolution BXD
The resolution of the free energy can be increased in the analysis of
a BXD simulation. There are two methods of doing this: a WHAM
approach or by box splitting.
2.3.1 WHAM for BXD
In our adaptation of the Weighted Histogram Analysis Method (WHAM)
the phase space within each box is divided up into smaller bins, shown
as dashed lines within each box in figure 2.5. Note that these bins are
for analysis purposes only and are not present in the simulation. Once
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the free energy has been calculated along the reaction coordinate the









where −∆Gn is the free energy of box n and the summation is the total




P (n) = 1. (2.13)
Given that the trajectory is in box m, the probability p (j) of being in
the jth bin within box m is the amount of time spent in bin j divided
by the total time spent in box m. This probability is then multiplied by
the probability of being in box m to give the normalised probability of
finding the trajectory in bin j compared to the rest of the entire reaction
coordinate:
P (j) = P (m) p (j) (2.14)
In this way, the resolution of the free energy can be increased
to an arbitrary level. This procedure is more simple and stable than
the WHAM algorithm used to recover Boltzmann free energies from
umbrella sampling.
2.3.2 Box Splitting
Box splitting is the other method of increasing the resolution of the free
energy. In the analysis stage each box is split into smaller parts, shown
in figure 2.6.
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Figure 2.6: the resolution of the free energy can be increased by adding
extra boxes in the analysis stage.
Note that the smaller box is only for analysis purposes and is not
present in the simulation. The rate constant kAB is calculated directly
from the BXD simulation using equation 2.6. The lower half of figure 2.6
is similar to the set-up shown in figure 2.2 hence equation 2.1 applies,
as kAB can be written as the product of an accelerated rate constant
and a correction factor:
kAB = kCBPCORR (2.15)











whereKCA is the equilibrium constant between boxes C and A (equation
2.7) and ∆GCA
RT
is the free energy difference between C and A, calculated
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as





is the ratio of the probabilities of finding the trajectory in box
C and box A. This ratio is equal to the ratio of the time spent in each box
which is obtained from analysing the plot of reaction coordinate against
time. By rearranging equation 2.16 and repeating for the rate constants
between box C and B it is possible to double the resolution of both the
free energy and the rate constants along the reaction coordinate. Figure
2.7 shows the effect of increasing the resolution of the free energy using
the BXD implementation of WHAM.
Figure 2.7: increasing the resolution of the free energy along end to end
distance for peptide P1 (see Chapter 4). The resolution was increased from
1 A˚ to 0.25 A˚ using our WHAM approach.
Now that BXD has been introduced the assumptions on which it
relies will be examined along with the conditions under which they are
valid.
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2.4 Decorrelation and Ergodicity
BXD relies on the assumption that the motion within a box is stochastic
and that sequential hits and velocity inversions are uncorrelated, i.e.
the time between hits must be longer than the correlation time. In
general this is not the case; a trajectory reflected from a boundary
can sometimes turn back quickly. These short-time-correlated events
need to be accounted for. This is done by removing the FPTs which
correspond to these fast events, a process known as decorrelation.43
Figure 2.8 shows a set of FPTs from a boundary in a BXD simulation.
Figure 2.8: a typical distribution of first passage times for a boundary be-
tween boxes in a BXD simulation. The initial very steep section corresponds
to fast correlated collisions which are removed from the set of FPTs used to
calculate the rate constant. This ensures that the assumption of stochastic
motion within each box is kept valid.
The log frequency distribution of FPTs shown in figure 2.8 is split
into two parts. The initial steep section comes from fast correlated colli-
sions against the boundary while the flatter section comes from ergodic
collisions where the trajectory has had time to come to equilibrium in
between hits. To decorrelate the statistics the FPTs from the steep
section are removed. Then the rate constant in equation 2.6 will only
be calculated with FPTs which are greater than the correlation time of
the system τcor.
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In practice this is done by defining a cutoff value τcor below which
FPTs are ignored. The free energy is then calculated for different values
of τcor which is increased until the free energy no longer changes. At
this point the statistics are decorrelated and the value of τcor at which
this happens is the characteristic correlation time for that system. An
example of decorrelation from an actual BXD simulation of a cyclic
peptide precursor S7 (see chapter 4) is shown in figure 2.9.
Figure 2.9: to remove FTPs corresponding to fast correlated motion a cutoff
value τcor is defined. This is varied until the free energy no longer changes. In
this example the free energy no longer changes when τcor is increased above
50 fs hence this was taken as the decorrelation time for this simulation of
cyclic peptide precursor S7 (See Chapter 4).
Once the statistics have been decorrelated equation 2.1 is valid as
dynamic recrossing no longer contribute to the MFPT.
The other condition that must be met is that the boxes must be
in equilibrium with each other. This is because equation 2.2 assumes
that the system is ergodic i.e. every point in phase space has an equal
probability of being visited by a trajectory. This is possible only if the
trajectory has time to forget its previous state after a collision. If the
box is too small then this will not be possible as the time in between
collisions with a boundary will be less than τcor so the trajectory will
34
2.4 Decorrelation and Ergodicity
never relax.
It is possible to check that the boxes are large enough by inspecting
the plot of the reaction coordinate value against time. One such plot
is shown in figure 2.10 for a box that is too small and a box that is
sufficiently large. If the box is too small then the trajectory can be seen
to hit a boundary very frequently whereas if the box is large enough
then the trajectory has plenty of time to explore the box in between
collisions with the boundary.
Figure 2.10: if a box is too small (left) then the trajectory hits the bound-
aries (red) too frequently and cannot equilibrate within the box. Decorrela-
tion here is impossible as there are no FPTs longer than the characteristic
decorrelation time. If the box is large enough (right) then decorrelation is
possible as the trajectory can explore the box and come to equilibrium in
between collisions with the boundary.
Another indication of the boxes being too small is if there is no
value of τdecor for which the free energy converges, as by definition if a
box were smaller than the correlation length then decorrelation would
not be possible.
For BXD to be accurate the rate constants must be converged. To
check for convergence the data from a BXD simulation is split in half.
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The free energy is calculated from half of the data as well as from the
full dataset. If the two free energies are the same then the simulation
has converged. See Appendix A for a more detailed description of how
BXD is used and a worked example of obtaining a free energy profile.
BXD has recently been used to get converged rates and free ener-
gies for processes up to a timescale of seconds44 including desorption of
ions from monolayers, diamond etching and peptide cyclization. Now
that BXD has been introduced along with an assessment of the con-
ditions under which it is valid, the next chapters will introduce some
recent applications and developments.
The aim of the first application reported here was to investigate
whether BXD could be used to succesfully model AFM protein pulling:
a very long time scale process with a parge protein molecule. By bench-
marking against readily available experimental data it was possible to
prove that BXD was capable of accuratly simulating a process which
traditionally is very computationally demanding, and to push the limits
of what could be achieved by using an enhanced sampling algorithm on
modest hardware. The second application was undertaken to show that
BXD has practical uses and can be used to help solve an urgent problem






Proteins are an important component of all bimolecular machines where
their mechanical properties are often crucial. Titin for example is a
molecular spring which plays a part in human muscle function; defects
on the part of titin have been linked to heart and lung failure.45;46 Me-
chanical resistance is also important for many other proteins such as
those that bind cells together in living tissue.47 The mechanical proper-
ties of proteins have been studied by Atomic Force Microscopy (AFM),
where an AFM probe is used to pull and unfold single protein domains
or chains of domains. The aim of these experiments is to shed some
light on protein folding and unfolding pathways and to discover why
certain proteins are more mechanically robust than others.45
The first AFM studies of the mechanical properties of proteins was
done by Rief, Gaub and Fernandez et. al. in 1995.48;49 These early stud-
ies used an AFM probe to measure the interaction force between two
strands of DNA. One strand of DNA was attached to a solid bead while
another was attached to the AFM tip. The two strands were brought
together for a certain amount of time and then separated, with the force
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needed to separate the strands being measured by the AFM probe. The
authors found that the force needed to separate the two strands varied
depended on how long the two strands were left in contact before being
pulled apart.
These studies were important because they took advantage of the
then recent discovery that functional groups could be attached to AFM
tips and used to pull apart large molecules, opening up a whole new field
of experimental biochemistry. The dependence of the force of interac-
tion between the DNA strands on the initial contact time suggested that
some dynamic process such as conformational change was responsible
for the interactions which were being probed.
This is highly relevent to computational studies because techniques
such as MD can in principle be used to directly observe the relationship
between the dynamics of a biomolecule and its resistance to force.
AFM is a technique whereby a sharp nano scale tip is attached to
a thin cantilever. The position of the cantilever can be measured via
laser reflection to a very high level of accuracy down to the nanometre
scale. Once in contact with a material the deflection of the cantilever is
known. Knowing this displacement as well as the force constant of the
cantilever allows the force acting upon the tip to be calculated. In AFM
protein pulling one end of a chain of protein domains, or concatemer,
is attached to the cantilever tip while the other is anchored to a solid
surface. The tip is then retracted causing the domains to unfold. This
is shown below in figure 3.1.
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Figure 3.1: the AFM protein pulling experiment. An AFM tip pulls apart
a chain of protein domains.
Two methods of AFM pulling are common: Force Clamp (FC)
where the tip is retracted at a constant force, and Velocity Clamp (VC)
where the tip is retracted at constant velocity. FC experiments50–54
produce a plot of extension versus applied force or extension vs time at
a range of forces, and VC experiments55–59 record the force exerted by
the cantilever against protein extension. Typical experimental traces
from VC and FC methods are shown below in figure 3.2.
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Figure 3.2: typical experimental traces from AFM pulling experiments. FC
mode (top) keeps the force constant and records extension against time, with
each step corresponging to a single domain unfolding. VC mode (bottom)
extends the protein at a constant speed and records the force exerted against
extension, with each peak in the trace corresponding to the unfolding of a
domain. The increasing height of the peaks is due to the domains unfolding
at higher forces due to the reduced elasticity in the chain as domains become
straightened out. Reproduced from Ref.60 with permission from The Royal
Society of Chemistry.
Comparison of these experiments with MD simulations should be
possible and will reveal otherwise inaccessible information about pro-
tein dynamics, which could lead to insights into the factors affecting
the mechanical stability of proteins as well as the mechanism of their
mechanical unfolding.
However the time scale of a typical AFM pulling experiment is
much longer than anything that can be simulated by MD. VC exper-
iments are performed on a timescale of microseconds to milliseconds
while FC unfolding can take as long as seconds. The free energy of
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AFM protein extension is very high meaning that it is a rare event not
often sampled by conventional MD.
In addition to the standard long timescale problem the dynamics of
AFM protein pulling varies with the pulling speed. High speed pulling
experiments tend to involve dynamical pathways whereas low speed ex-
periments involve a more stochastic process where more pathways and
conformations are explored. Despite attempts to increase the timescale
of simulation or reduce the timescale of pulling, simulation and experi-
ment have not yet met in the middle.
In this chapter BXD is applied to the AFM protein pulling exper-
iment to replicate both VC and FC modes.
Experimental data are reproduced and insights into the mechanical
unfolding process are presented. AFM unfolding will be simulated for
three protein domains: Protien L which binds antibodies, I27 which
forms part of the muscle protein Titin and IM9 which plays a role in




Figure 3.3: the structures of the protein domains that feature in this study.
Structures are taken from the RCSB Protein Databank: 1IMQ (IM9), 1TIT
(I27) and 1K53 (Protein L).
3.1.1 Existing Methods of Simulation
Most simulations of the AFM experiments involve the application of an
artificial force to the system; a technique known as Steered Molecular
Dynamics (SMD).61 A virtual harmonic spring is attached to each end
of the protein. Moving the springs apart at constant velocity applies a
force which pulls the ends of the protein apart in a similar way to how
the AFM experiment operates. The extension of the spring is recorded
as the protein unfolds and this provides a plot of force versus extension
which mimics the VC experiments. SMD can also mimic FC experi-
ments by applying a constant force along the vector between the ends
of the protein, pulling them apart with a constant force rather than at
a constant speed.
SMD has been used to investigate the mechanical unfolding of a
number of protein domains. The I27 domain of titin is an all beta
sheet domain which is well studied by experiment and simulation. VC
experiments have found that I27 has a high mechanical strength and
consequently unfolds at a high pulling force of around 150 to 200 pN
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at a range of pulling speeds between 1 and 5000 nm per second.55;62 As
the force builds up I27 extends by a very small amount until the peak
unfolding force is reached, after which a rapid collapse of the structure
leads to large extensions and a decrease of the force.57;62 Theoretical
studies63–67 have used SMD to pull I27 and have found that the me-
chanical behaviour comes from the backbone hydrogen bonds between
the terminal beta sheets.
Early SMD work by Schulten, Rief and Fernandez et. al.55;64–67
reported the sequence of events undergone by I27 when a force is ap-
plied in simulation. The initial 10 A˚ of extention does not result in
any structural change. After the extension increases to around around
14 A˚ the A’ and G beta strands slide past each other as 6 hydrogen
bonds between them rupture. Figure 3.4 shows these strands in I27
and the hydrogen bonds between them. After these strands separate
the remaining strands fail one by one at lower pulling forces until the
molecule is linear.
Figure 3.4: the structure of I27 and the hydrogen bonds between the A’ and
G strands which are responsible for the mechanical strength of the domain.
Protein L is a mixed alpha + beta domain which shows similar me-
chanical strength and unfolding behaviour to I27.68 SMD was used to
investigate the mechanical unfolding of protein L61 which was found to
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be similar to I27 in that a cluster of backbone hydrogen bonds between
beta strands withstand a high force and then suddenly fail, leading to
complete unfolding. SMD suggests61 that when the force is initially ap-
plied the N terminal beta strand reorientates to align with the applied
force. This minor conformational change yields a very small extension
yet is responsible for the peak unfolding force. This rearrangement dis-
rupts the hydrogen bonds between the N and C terminal beta strands,
leading to a rupture of the contacts between them. The structure of
Protein L and the hydrogen bonds responsible for the initial force re-
sistance are shown below in figure 3.5. The main difference between
Protein L and I27 was found to be that I27 populates a number of in-
termediate states along the unfolding pathway while Protein L unfolds
via a simple two state system.61
Figure 3.5: the structure of Protein L and the hydrogen bonds responsible
for the initial resistance of the domain according to SMD studies61.
All alpha domains such as IM9 unfold at much lower forces than
all beta, alpha + beta or alpha/beta domains.57;61 This is thought to be
due to the absence of a cluster of backbone hydrogen bonds which are
loaded all at once, and share the force as is found in beta sheets. Instead
the backbone hydrogen bonds are loaded sequentially and fail one at a
time, leading to a gradual unravelling at low force rather than the initial
resistance followed by sudden failure displayed by I27 and Protein L.61
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This view is confirmed by computational studies where SMD was used
to unfold a number of all alpha domains.69–71 In summary SMD has
been used to show that the secondary structure of a protein or domain
is a major factor in determining the resistance to pulling.55 Another
major factor is the direction in which the force is applied, with proteins
being much stronger if their topography results in the force being ap-
plied along the long axis of betra strands which are hydrogen bonded to
each other, due to the fact that the lead is then shared between multiple
hydrogen bonds.57;61, such as with I27 and the A’-G mechanical clamp
(see figure 3.4).
SMD applies a pulling speed or force that is several orders of mag-
nitude greater than that of the corresponding experiment. The effect of
this on the validity of the simulations is under debate. Experiment has
shown that for I27 the excessive pulling speeds and forces used have not
negatively impacted the results of the simulations, however it is possible
that it is a problem for systems that do not share the same mechanical
characteristics as I27.71 BXD differs in that no force or pulling speed
is applied, instead the system diffuses along the reaction coordinate of
end to end distance with no modification of the potential.
3.2 Method
Calculations were performed using the BXD subroutine implemented in
CHARMM.72 After every time step the BXD code recieves the atomic
positions and velocities from the CHARMM integrator which are used
to update the value of the reaction coordinate. If the value of the reac-
tion coodinate has change such that a boundary has been crossed then
the velocity of each atom is inverted with respect to the reaction coordi-
nate (see figure 2.1), and the new inverted velocities are passed back to
the integrator. The inversion is performed in the centre of mass frame
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to converve linear and angular momentum.
The reaction coordinate was chosen as the distance between the
two termini of the protein domain as this would correspond to the co-
ordinate sampled by the AFM pulling experiments. This end to end
distance coordinate was later translated to extension by subtracting
the equilibrium value. The EEF1 (Effective Energy Function 1) im-
plicit solvent model73 and CHARMM 19 force field were used for the
simulations along with the Langevin thermostat set to 303 K. To begin
with the PDB structures for the three domains were equilibrated un-
der the forcefield and solvent model for 500 ns before BXD simulations
commenced.
For IM9 and Protein L boxes were placed at intervals of 0.75 A˚
from 11.25 A˚ to 320.25 A˚, and from 21 A˚ to 320.25 A˚ respectively.
For I27 the boxes were at intervals of 0.5 A˚ from 20 A˚ to 330 A˚. Be-
tween 5000 and 2000 inversion events were required in each box before
a boundary could be passed. Initially the reaction coordinate was sam-
pled downwards from zero extension to the lowest boundary in order to
fully explore the local minimum before the direction was reversed and
the protein domain began to extend. Sampling was continued until a
linear conformation had been achieved.
Simulations were also carried out with boxes at intervals of 0.5 A˚,
0.25 A˚ and 0.125 A˚ in order to ascertain that the result was independent
of box size and placing. The free energy along end to end distance for
protein L, calculated at different box sizes, is shown in figure 3.6.
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Figure 3.6: free energy along end to end distance for Protein L with box
sizes of 0.5 A˚ (red) and 0.75 A˚ (blue). Solid lines represent the average
free energy of 10 individual trajectories. Dotted lines show one standard
deviation. The uncertainty resulting in the distribution of FPTs used to
calculate the rate constants (see Chapter 2) is very small as the trajectory
remains in each box for a long time. The more significant uncertainty shown
here result from each trajectory sampling a slightly different pathway. The
uncertainty at small extensions is very small as the unfolding pathways are all
the same initially: The force builds up until the hydrogen bonds between the
terminal beta strands rupture. At higher extensions the uncertainty increases
as a wider range of pathways can be accessed as units of secondary structure
break down.
It is clear from figure 3.6 that the free energy does change slightly
with box size. However for Protein L, 0.5 A˚ was found to be the limit of
how small the boxes could be before it became impossible to decorrelate
the trajectories. Presumably this is because the correlation length for
Protein L is slightly below 0.5 A˚. With 0.75 A˚ boxes the decorrelation
procedure worked well while with larger boxes the simulation took too
long. Because of this it was decided to use a box size of 0.75 A˚. For I27
the trajectories were well decorrelated with a box size of 0.5 A˚ while
larger boxes did not allow the simulation to proceed, hence a box size of
0.5 A˚ was chosen. For each protein domain 30 unfolding BXD runs were
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obtained. The total simulation time for each domain was of the order
of tens of nanoseconds. The decorrelation time used in the procedure,
which removes correlated short time events, was found to be 600 fs for
each system. This value was obtained by calculating the free energy at
a number of different decorrelation times and taking the smallest value
for which it had converged (see figure 3.7).
Figure 3.7: decorrelating the free energy for I27. Different decorrelation
times, shown in femptoseconds by the number on the end of each line, were
used to calculate the free energy. On going from 600 to 1000 fs the free energy
no longer changed so 600 fs was taken as the correlation time for I27.
The set of box-to-box rate constants yields both the free energy
and all the information necessary for a description of the kinetics of
unfolding along the pulling reaction coordinate.
3.2.1 Treatment of Solvent Effects
Including water molecules in the unfolding simulations would be pro-
hibitively expensive due to the very large box that would be needed
to cover an extended protein. Therefore the solvent effects are treated
implicitly with the EEF1 solvent model73 which modifies the potential
energy of the system to mimic the effects of water. The solvation free
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where N is the number of solute atoms, ∆Grefi is the solvation free
energy of atom i, and Vj is the volume of atom j. The functionf(rij) is











where rij is the distance between atoms i and j, Rj is the Van Der
Waals radius of atom j, λj is the correlation length of atom j (3.5 A˚ for







where Gfreej is the solvation free energy of the isolated atom j, which is
close to ∆Grefj . The main point of equation 3.1 is that for each atom,
the solvation free energy is taken to be that of itself fully immersed in
water, minus a term to account for the atom being partially exposed.
The solvation energy from equation 3.1 is added to the potential energy
of the solute derived from the force field:
WEEF1 = U (r) + ∆Gslv (3.4)
where WEEF1 is the new effective energy under the EEF1 model, U (r)
is the potential energy from the force field and Gslv is the solvation free
energy from equation 3.1. While the EEF1 model takes the solvent into
account at the molecular scale, Langevin Dynamics is used to replicate
the bulk properties of water. This is done by modifying the Newtonian
equations of motion to take into account friction and random collisions
with water molecules, which is added onto the force derived from the
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gradient of U (r), the potential energy derived from the force field. The
Langevin equation is defined as
Fi (t) = mia+ γivimi +
√
2γkBTmiRi (t) (3.5)
where Fi (t) is the force acting on atom i as a function of time, γi is
the friction coefficient between water and atom i, kB is the Boltzmann
constant, T is the temperature of the simulation and Ri (t) is a function
introducing random collisions between atom i and water. Langevin Dy-
namics allows the temperature of the simulation to be controlled as T
affects the amplitude of the thermal jostling experienced by the solute
atoms. The friction coefficient γi allows the viscosity of bulk water to
be replicated.
Mechanical unfolding has for I27 at least, been shown to be partly
mediated by water as after the initial rupture of the A’-G hydrogen
bonds (see figure 3.4) the hydrophobic core of the domain is destabilised
by the water which acclerates the collapse of the protein structure.55;64
It is also possible that the hydrogen bonds which are broken in the A’-
G rupture are re-formed with water which would lower the barrier to
unfolding. However the relaxation time of water is typically between 1
and 2 ns74 meaning that, for a simulation using explicit water, unless a
conformation persists for at least this time then the arrangment of the
water molecules around it will not be realistic and the conformation will
not be properly stabilised. Because accelerated sampling methods such
as BXD and SMD often involve rapid conformational change, with SMD
unfolding simulations often completly unfolding the protein in around
a single nanosecond63–67, it may be that implicit solvent models are the
more appropriate choice.61
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3.3 Results and Discussion
3.3.1 BXD Calculation of Unfolding Free Energies
and Replication of VC Experiments
Free energies as a function of the end-to end distance and their gradi-
ents are shown in figures 3.8, 3.9 and 3.10 for I27, protein L and IM9
respectively. Points A to E indicate particularly important regions of
the free energy, corresponding to minima and maxima of the force. The
snapshots of the structures at those regions are also shown. The dashed
line and dotted line represent one standard deviation from the calcu-
lated average. For the free energy profiles this was calculated by taking
the standard deviation of the ensemble of free energies from each indi-
vidual unfolding trajectory. Each free energy profile was converted into
force by differentiation and then the average force and standard devia-
tion were taken from the ensemble of individual force versus extension
plots.
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Figure 3.8: free energy and force along the pulling coordinate for I27.
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Figure 3.9: free energy and force along the pulling coordinate for Protein
L.
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Figure 3.10: free energy and force along the pulling coordinate for IM9.
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The main insights from the above figures are that the mechanical
strength of a protein depends on the secondary structure of the region to
which the force is initially applied, which can be determined by observ-
ing which region is the first to fail. For I27 the force increases rapidly,
to a high value with little extension until hydrogen bonds bentween the
A’ and G beta strands (see figure 3.4) rupture, in agreement with SMD
studies63–67. For IM9 the force is loaded onto alpha helix; the hydro-
gen bonds between them fail sequentially leading to gradual unfolding
of the whole domain at low forces. Protein L has a mixture of alpha
helixes and beta sheets and and a force-extension profile which is simi-
lar to that of I27. The initial force is loaded onto a series of hydrogen
bonds between beta strands rather than onto an alhpa helix, support-
ing the suggestion that the resistance depends on the local structure
of the region which is first to experience the force. The partially un-
folded structures of Protein L and I27 show that beta sheets fail one at
a time after the initial rupture which leads to more peaks at lower forces.
The structures along the unfolding pathway (figures 3.8 and 3.9)
show that the initial rupture of I27 and Protein L exposes the hydropho-
bic core to the water which may result in issues with the implicit solvent
model, as the hydrophobic effect and water stabilisation of ruptures hy-
drogen bonds will not be fully reproduced, however because of the fast
time scale at which these conformations change in the simulation an
implicit solvent model may still be better.61
It should be noted that mechanical unfolding is a completely differ-
ent process to thermal unfolding in vivo.75 While thermal unfolding free
energies feature small barriers separating stable states, the AFM probe
pulls the protein apart, forming an unnatural linear conformation with
a very high free energy. This is supported by the fact that there is no
correlation between the mechanical and thermal stability of a protein.76
The difference between the two kinds of unfolding is illustrated in figure
3.11.
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Figure 3.11: in vivo unfolding features stable states separated by small
energy barriers. Unfolded states retain much of their secondary structure.
With mechanical unfolding the AFM probe pulls the protein apart to higher
and higher free energies along an unnatural pathway.
As the free energy represents thermodynamical free energy along
the reaction coordinate x, by definition the change of the free energy
is equivalent to mechanical work required for displacement along the
reaction coordinate (protein extension in this case), and mechanical







where W is the work required, provided that the extension is slow
enough for equilibrium thermodynamics to be valid. In the limit of
higher speed the kinetics of protein pulling should be considered in
more detail. As the kinetics of mechanical unfolding changes with pul-
ing speeds a number of models have been developed to describe this de-
pendence.77–79 In principle BXD theory can be applied to a wide range
of pulling speeds and the relationship of the pulling force and pulling
speed can be obtained, but this study focuses on the limit of slow speed
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where simple thermodynamical argument leads to equation 3.6.
Some features of the free energies are similar for all three protein
domains. At low extensions near equilibrium there is a well, which is
steep for the beta containing domains I27 and L, and relatively smooth
and broad for the all alpha IM9 domain. This difference is due to the
fact that, for I27 and protein L, the initial force is loaded onto beta
sheets which hold out to high forces before suddenly rupturing, whereas
with IM9 the initial force is loaded onto alpha helices which rupture
gradually at low forces.45;57;62 This well is situated around the global
minimum along the extension coordinate and corresponds roughly to
the equilibrium native structure of the domain under the conditions of
the simulation.
The force curves generated by BXD have a similar shape to those
produced by SMD, however the forces reported by SMD are at least
an order of magnitude higher than those from BXD, and also from any
experimental force curves. This discrepency in the SMD force curves
is due to the artificial forces used in the simulation which are several
orders of magnitude greater than those used in the AFM experiments.
For all three proteins the equilibrium well is followed by an in-
flection point before a region of less steep free energy is reached. This
inflection point corresponds to breaking the native structure once a peak
unfolding force is reached, corresonding to a transiton from point A to
point B in figures 3.8 to 3.10. I27 and Protein L have a deeper equi-
librium well and a more pronounced inflection point than that of the
alpha domain IM9. This is due to the fact that beta sheets offer more
mechanical resitance than alpha helixes.45 On going from the bottom of
the well to the inflection point does not result in significant change in
the equilibrium structure, before a sudden rupture between beta sheets
leads to a reduction in the force. This is due to the brittle nature
of beta-sheets; initially the force is shared between multiple hydrogen
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bonds which fail suddenly, allowing the beta sheet to unravel easily.57;62
This is responsible for the sudden reduction in the force on going form
point B to C in figures 3.8 to 3.10. The hydrogen bonds responsible for
the initial resistance are shown in figure 3.12.
Next the other beta sheets are loaded and fail sequentially in a
similar brittle manner, until they have all unfolded and the force again
increases as a linear conformation is reached (point D). The shape of
the free energy curve calculated from fully atomistic simulations is very
much in line with the suggestions made to explain experimental results80
and theoretical models.81
For the alpha-protein IM9 after the initial increase the force re-
mains flatter and shows smaller peaks and troughs than those of the
I27 protein. This is because the connections within alpha helices, and
the helices themselves fail more gradually leading to lower forces. This
is in agreement with the literature; Brockwell reports that the all alpha
IM9 domain unfolds below the noise limit of the experiment45 and SMD
simulations69–71 suggest that the mechanical weakness of alpha helices
is due to the fact that only one backbone hydrogen bond is loaded at a
time, leading to sequential failure and an unravelling of the helix.
Protein L is a combination of beta sheets and alpha helices. Ini-
tially the force profile and free energy is similar to that of I27 as the
force is initially resisted by beta sheets in both proteins. After the first
beta sheet fails (see figure 3.12) a strong intermediate structure remains.
The resistance of a beta sheet in this intermediate is responsible for the
large force peak at moderate extensions of Protein L (going from points
C to D). After this beta sheet fails the force curve flattens out as an
alpha helix unravels gradually before the remaining structure fails and
a linear conformation is reached (point E).
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Figure 3.12: Structures responsible for force peaks in I27 and Protein L.
Breaking the native structures (top two) requires the maximum pulling force
as they represent the bottom of steep free energy wells around the native
structure. The hydrogen bonds responsible for the initial resistance are shown
as blue lines. These bonds rupture simultaneously causing a large structural
change and rapid extension of the domain. In protein L there are two systems
of hydrogen bonds, which unzip sequentially. The structure of the interme-
diate responsible for the hump in the force curve of protein L is shown at the
bottom, corresponding to point D in figure 3.9. Arrows indicate the direction
and points of application of the experimental pulling force.
In the experiment it is not a single protein domain but their se-
quence, a concatemer that is pulled. However, knowing the free energy
of an individual domain and its gradient, and assuming that the domains
extend independently and sequentially one by one allows reconstruction
of the experimentally observed dependence of the force vs protein ex-
tension, shown by figure 3.13 alongside experimental force curves.
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Figure 3.13: The teeth due to extension of a chain of the proteins for I27
(frame a) and Protein L (frame b). When one domain is extended to the point
where the force increases to the value necessary to break out of the native
well of the next domain, it’s native structure quickly passes the inflection
point and breaks down leading to the sharp fall of the pulling force. Then
the process is repeated. Frames a and b correspond to I27 and Protein L
respectively. The teeth are generated by repeating the section of the force
curve beyond the initial peak force and the point where the force reaches
this value again. This mimics the experimental force trace where a chain of
domains unfolds one at a time. Experimental force curves for I27 (frame c)
and Protein L (frame d) are shown for comparison. I27 experimental data
is taken from Ref.62 and Protein L data from Ref.61 with permission from
Elsevier.
As shown by figure 3.13 frame a, for I27 BXD qualitatively repro-
duces the overall structure of the experimentally observed teeth in the
dependence of force on extension. The peak force and the length of the
tooth are both well reproduced. Frame b of figure 3.13 is the same as
frame a but for Protein L. The main peak (DB for I27, EB for Protein
L) in both frames is reached when an expanding member of the con-
catemer reaches a linear extension and the force becomes sufficient to
break the native structure of the next member of the chain. Then the
process is repeated.
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No multiple teeth can be obtained during the extension of a se-
quence of IM9 as there is no sharp decrease of the force at the point
of inflection. The slope of the free energy for the alpha-protein IM9 in
figure 3.10 is lower than that of protein L and I27 respectively. These
observations are in agreement with experiment where alpha domains
were found to be less robust and showed neither significant peaks nor
teeth in the dependence of the force vs extension.
In a number of experiments the humps of the force were observed
and also attributed to the structural changes in small proteins,55;80
which are also present in our simulations. The experimental depen-
dence of the force on the extension is typically less structured than
those shown by figures 3.8 and 3.9 as BXD provides the free energy and
force curves at a higher resolution that the AFM experiments. This has
allowed the identification of an intermediate structure in the mechanical
unfolding of Protein L (see figure 3.12.
The assumption that the unfolding events witnessed in the concate-
mer are equivalent to the unfolding in isolated domains is common.50;82
However the extent to which it is valid is not fully resolved as coop-
erative motion of the concatemer and domain-domain interactions can
affect the results of the experiment.83 In certain systems domains have
been shown to unfold together rather than independently70 and in VC
experiments the unfolding forces depend on the number of domains in
the concatemer.82;83
In a recent study,84 Uribe et.al. used umbrella sampling to calcu-
late the free energy along end to end distance for a set of small peptides.
The free energies obtained are very similar in shape to those shown in
figures 3.8 to 3.10. In particular, the free enregies reported by Uribe
show a distinct equilibrium well representing the native structure, fol-
lowed by an inflection point leading to a region of less steep free energy.
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These results are very much in line with the findings presented here and
suggest that the free energies obtained by BXD are correct. Despite
the free energies presented by Uribe being for small peptides of around
10 amino acids, the reaction coordinate used by Uribe is that of me-
chanical unfolding and the basic shape of the free energy profile is much
the same as those generated by BXD for larger proteins, suggesting the
mechanical unfolding free energies calculated by BXD are of the correct
form.
3.3.2 BXD Kinetic Description of FC Experiments
Force Clamp is another mode of AFM pulling in which proteins are
pulled with a constant force and the distribution of unfolding times is
measured, giving the rate constant for unfolding at that particular force.
Another quantity reported in the FC experiments is the protein exten-
sion as a function of the pulling force. Typical measured unfolding times
(inverse rate constants) are in the order of seconds,50–54 which neverthe-
less can be within the reach of BXD. Figures 3.14 and 3.15 summarize
the results of modelling the FC experiments. It is clear from figures 3.8
to 3.10 that unfolded states would never be reached as the free energies
are too high. It is thought that the application of force along the pulling
coordinate tilts the free energy profile and allows mechanical unfolding
to occur.85;86 To test this theory the free energies obtained with BXD
were adjusted to take a pulling force into account. If the force mod-
ified free energies allow FC experimental data to be reproduced then
the theory of force tilted free energy profiles for mechanical unfolding is
supported.
Frame A shows the force adjusted free energy obtained by modi-
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where ∆x is the box size. For each free energy profile an end point
was chosen to correspond to the maximum extension under that pulling
force. The choice of end point depended on the shape of the free energy.
For low forces (< 30 pN) the free energy rises monotonically with no
transition state or well present, which implies no or extremely slow
unfolding. In this case the end point was defined as the inflection point
in the free energy in the initial native well at which peak force is reached.
For intermediate forces (30 to 50 pN) the free energy is tilted to show
two wells, the native structure well at zero extension and a well at
extensions of 50 to 100 A˚. In this case the second well was chosen as the
final state because it represents a transition from the native structure
to a stable unfolded conformation. At higher forces (> 60 pN) the force
adjusted free energy shows three wells and the final well was chosen as
a final state. The kinetic end points are shown by frame A in figures
3.14 and 3.15 by the arrows and the dependence of the endpoint on the
external force, that is the extent to which the domain unfolds at each
force, is shown by frame B in comparison with that of experiment.52
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Figure 3.14: free energies for Protein L obtained with modified rate con-
stants (equation 3.7) which include an additional factor taking into account
the external force in the FC experiment (frame A). The assumed end points
are shown by arrows and are also shown in frame B as a function of the
applied force (red squares) and compared with the experimental data (black
line). The estimated rate constant of unfolding is shown by the red line in
frame C and compared with experiment shown by black line. For the force
below 60 pN the theoretical rate constant remains flat, underestimating the
experimental data by 2 orders of magnitude. The rate constent then grows
fast at higher forces as the unfolding becomes barrierless. It must be noted
that the experimental error bar is not known but may be significant.
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Figure 3.15: free energies for the protein domain I27 obtained with modi-
fied rate constants (equation 3.7) which include additional factor taking into
account external force in the FC experiment (frame A). The assumed end
points are shown by arrows and are also shown in frame B as a function
of the applied force (red squares). Experimental data is absent here. The
estimated rate constant of unfolding is shown in frame C by the red line
and compared with experiment shown by the black line. For the force above
60 pN the theoretical rate constant starts growing fast as the unfolding be-
comes barrierless. It must be noted that the experimental error bar is not
known but may be significant as the experiment is unable to detect very fast
unfolding events.
There is significant difference between the calculation and experi-
ment for the extension versus force data as well as with the unfolding
rates versus applied force data (frames B and C). This is probabily be-
cause the rates of unfolding, as well as the amount to which a domain
extends for a given force are highly dependent of the height of the free
energy barrier for unfolding. The main barrier(s) to unfolding, for both
I27 and Protein L, for forces above 20 pN are in a region of the PMF
where the uncertainy is quite high (see figures3.8 to 3.10 ) and hence
this slight lack of convergence in the important regions of the free energy
could explain the large discrepency with experimental data. It should
also be noted that quantitative agreement with all aspects of experi-
mental data for such a long timescale process as AFM induced infolding
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would represent an unprecedented achievement in atonistic simulation.
Considering the modest resources used in the simulation and fact that
BXD is a simple and fast algorithm, the results obtained with BXD,
especially in the reproduction of the VC experiment (figure 3.13) are
generally encouraging.
In order to estimate the unfolding times, the matrix of rate box-to-
box rate constants M (see Chapter 2 equation 2.10) was truncated by
removing all boxes beyond the box which represents maximum exten-
sion (frame B figures 3.14 and 3.15). The rate constant corresponding
to motion from this last box to the box at a lower extension was then
set to zero. This was done to mimic the FC experiment where the pro-
teins are extended irreversibly. The eigenvalues of the kinetic matrix
now determine the kinetic rate constants of unfolding at this particular
force. Usually the lowest eigenvalue of a kinetic matrix M is separated
from all other eigenvalues and determines the reaction characteristic
rate constant for unfolding at that force. This was repeated for a range
of experimental forces. Frame C in figures 3.14 and 3.15 compares the
calculated rate constanta with experiment. For medium force the cal-
culated characteristic times are within the range of 102 to 103 seconds
which is approximately 2-3 orders of magnitude higher than the reported
experimental result. At higher forces (c. 50 pN) the reaction becomes
barrierless, unfolding becomes very fast and the rate constant increases
dramatically.
Quantitative agreement with experiment has not been achieved
here but it must be taken into account that BXD estimates the reac-
tion rates in the order of minutes based on fully atomistic simulations
without any modifications of the force field. However the qualitative
agreement with the FC experiment suggests that the tilting of the free
energy by the applied force does indeed allow mechanical unfolding to
occur.
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Comparison of BXD calculations with FC experiment allows mod-
ifications of the force field to be suggested which may improve the
agreement with experiment. If the equilibrium well in the free energy
is steeper and the region after the inflection point is flatter, then the
agreement between experiment and theory in the frames on the right of
figures 3.14 and 3.15 should improve. The former can be achieved by
adjusting the parameters of hydrogen bonds responsible for the gradient
of the free energy on the right hand side of the equilibrium well.
Also in these simulations an implicit solvent model was used to
reduce the cost of the simulations, common practice in mechanical un-
folding simulations.61 There is evidence that the barrier to unfolding is
lowered by the presence of water molecules. For example, with a protein
such as I27 where unfolding is resisted by multiple hydrogen bonds in
beta sheets it is thought that ruptured hydrogen bonds can reform with
water rather than within the protein, lowering the energetic cost of rup-
ture and hence reducing the height of the unfolding barrier.55;64 Using
explicit water instead of implicit solvent model also may improve the
agreement with experiment reproduce this but this is computationally
expensive.
Perhaps an approach similar to that outlined by Korotkin et. al.
could be used, which treats explicitly only the water molecules which
are in close proximity to the protein, and the rest of the water box by
a hydrodynamic approach.91
Similarly to the velocity clamp experiments, force clamp experi-
ments can be affected by the fact that AFM experiments pull a concate-
mer of many protein domains. It is assumed that each domain unfolds
fully and independently of the others. Based on this assumption each
of the steps in the extension vs time trace of FC pulling is assumed to
be from a single domain and the data for each domain is averaged.
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However if this independence of unfolding events is not wholly
correct then the situation becomes complicated. Cooperative motion of
the concatemer, interactions between domains and energy storage in the
chain would make analysis of the experimental data much more difficult
and inconclusive. The debate as to whether this central assumption
is valid is ongoing51 and AFM studies of the refolding of a concate-
mer show that cooperative motion drives the process.92 Simulation of a
concatemer and investigation of cooperative effects will be a future goal.
It is also possible that the measured force at which unfolding events
occur does not exactly correspond to reality. Thermal fluctuations in
the position of the AFM tip may cause protein domains to unfold pre-
maturely at forces other than that registered by the experiment53 and if
the concatemer is not pulled perpendicular to the solid surface to which
it is attached then the force along the pulling coordinate could be less
than what is measured.53
A key difference between simulation and the AFM experiment is
the dependence of unfolding force upon the direction in which the force
is applied to the domain. Secondary structure alone does not fully ex-
plain the mechanical resistance of proteins,87 as some proteins, such as
I27 and TNfn3 with similar secondary structure in the region to which
the force is apllied, show dissimilar unfolding forces. Brockwell et. al.88
demonstrate that the dependence of the mechanical resistance upon the
direction of applied force is due to the arrangement of the secondary
structure with respect to the angle of the force. When the force is ap-
plied in parallel to beta strands the load is shared between multiple
hydrogen bonds resulting in a strong resistance, and when the load is
applied perpendicular to the beta strands the hydrogen bonds rupture
one at a time, leading to less resistance.
Carrion-Vazquez et.al.89 show that the choice of linkage between
the protein domains in the concatemer affects the direction in which
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force is applied to each domain and hence the force at which they un-
fold. As linkages are not included in the BXD simulations it is possible
that this explains some of the discrepency between experimental data
and the simulation. Zoldak and Rief90 suggest that, as proteins un-
fold at different forces when pulled in different directions, end to end
distance could be an unsuitable choice of reaction coordinate for me-
chanical unfolding, however for most systems the main features such
as barrier height and position are captured sufficiently. BXD does not
apply a force to the protein, instead the dynamics along the coordinate
of end to end distance are simulated, with extension occuring along the
vector between the N and C terminals. While this may be incorrect
due to the discussed effects of pulling direction relative to the hydro-
gen bonds between beta strands, it is probable that BXD does not fail
on this account because overall agreement with experimental unfolding
forces are good (figure 3.13). Also the mechanical clamp between the
A’ and G beta strands is correctly identified as the key structure re-
sponsible for I27s mechanical strength (see figure 3.4), suggesting that
the dynamics simulated with BXD are similar to those of the AFM ex-
periment and the anisotropy of a domains mechanical strength has not
had a significant effect on the results of the simulations.
After a domain unfolds the AFM tip recoils and the force is no
longer applied to the concatemer for a certain amount of time.93 Any
unfolding events that take place in less time than this recoil time will
be missed. In the experiments from which the data is taken for com-
parion to the BXD simulation this detection threshold is roughly 5 ms,
corresponding to log10(kunfold) ≈ 2.3. This effect would affect the ex-
perimental unfolding time vs force curve as fast unfolding events would
be missed because the force is not applied for this period. Based on
the above factors the results obtained by BXD are in good qualative
agreement with the FC experiments.
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Recently it has been discussed in the literature whether the kinet-
ics of the FC experiment can be described by a single rate.92 In principle
BXD allows reproduction of complicated kinetics. For example it has
been shown that given the initial conditions peptide cyclization kinetics
can exhibit both simple single exponential and complicated power law
behaviour.94 Describing this phenomena in AFM experiments will re-
quire more work. However this study only shows that BXD is capable of
recovering realistic rates and very long characteristic times observed in
the FC experiments. In future, quantitative agreement with experiment
will be attempted by addressing the issues discussed above.
3.4 Conclusions
The above discussion can be summarized as follows:
1)BXD reproduces realistic pulling forces (in the order hundreds of pN)
observed in VC experiments.
2)Initially the force increases without affecting the equilibrium structure
significantly. When a threshold force is reached a structural unit fails,
followed by the sequential failure of the remaining structural units at
lower forces until a linear conformation is reached.
3)Beta-sheets resist the force well before failing abruptly leading to pro-
nounced peaks and troughs in the force vs extension curves, whereas al-
pha helices fail gradually at lower forces, leading to a flatter force curve.
4)The force vs extension curves reproduced by BXD reveal intermediate
structures along the mechanical unfolding pathway. These structures
can easily be visualized.
5)Qualitative agreement with the FC experiments has been achieved on
unfolding processes up to a timescale of seconds. The assumption that
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the application of force tilts the free energy landscape, thus allowing me-
chanical unfolding to proceed,85;86 has been confirmed.
We believe that this is the first time that the mechanical unfolding
of proteins has been simulated under realistic conditions without artif-
ically high pulling forces, providing reliable confirmation of the factors
affecting mechanical stability as well as the unfolding pathways and free
energies
3.5 Further work
The following issues will be addressed later:
1) - The calculatons will be repeated with explicit solvent to achieve a
better agreement with experiment.
2) - An attempt to go beyond the assumption of slow pulling will be
made. This may allow investigation of the dependence of the maximum
pulling force on the pulling speed observed in experiment. BXD is well
suited for this as it provides kinetic information along the whole reac-
tion coordinate.
3) - Simulating the extension of a concatomer may make it possible to
assess the importance of cooperative effects and also answer the question
whether the humps which correspond to the breaking of the structures
within a single member of the concatomer are not detected. This is
within the reach of BXD but will require more work.
Thus BXD is an efficient theoretical tool to study long time processes
such as mechanical unfolding.
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Chapter 4
In Silico Screening of
Medicinal Cyclic Peptides
4.1 Introduction
This chapter presents another application of BXD: predicting the propen-
sity of amino acid sequences to form cyclic peptides.
Traditional drug discovery has focused on designing small molecules
which work by binding to a particular bimolecular target responsible for
the disease or condition.95;96 Binding to the target causes it to lose its
biological activity, for example by blocking the active site of an enzyme.
Despite these insights pharmaceutical research and development has
been declining in efficiency for several decades.97–99 The situation has
become especially urgent in the field of antibiotics, where widespread
resistance to conventional small molecule drugs is a major threat to
world health.100–102
One factor in the reduced effectiveness of drug discovery is that,
despite the recent increases in the understanding of the mechanisms of
disease, the number of possible targets for a conventional drug or Active
Pharmaceutical Ingredient (API) is highly limited. Indeed, traditional
small molecule APIs are, in general, only effective against targets that
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contain a discrete hydrophobic pocket or are integral to the outside or
membrane of a cell. Together this accounts for only twenty percent of
all known disease related targets.98 Another problem facing drug devel-
opment is the low solubility of many APIs103;104 and their inability to
be taken orally.96;97;105
Overcoming these problems will require a dramatic innovation in
drug discovery along with the introduction of new classes of compounds.97;98
Cyclic peptides are a promising candidate with much potential for pro-
viding new types of antibiotic and anti-infection drugs.97;98;105;106;122
Consisting of a ring of between 5 and 30 amino acids, cyclic peptides
have a number of features which allow them to target biomolecules
which cannot be affected by traditional small molecule APIs.106;107 For
example, their large size and complexity allows more reliable and selec-
tive binding to large extended binding sites as well as the targeting of
protein-protein interactions, both cases where conventional drugs strug-
gle.97;98;108–112
Cyclic peptides provide a degree of pre-organisation which reduces
the entropic cost of binding while retaining enough flexibility to inter-
act well with dynamic protein targets which are very difficult for small
molecule APIs.106;107;113 There is also evidence to suggest that a cyclic
conformation helps improve other areas of performance such as mem-
brane permeability, metabolic stability and the overall interaction with
the body.106;107;114 as well as an increase in the overall stability of the
molecule over a linear equivalent.98;108–112
Since the first cyclic peptide drug Gramicidin S (figure 4.1) was
introduced as an antiseptic in 1944115 there are now at least thirty
cyclic peptides on the market with more in clinical trials97 most of
which are antibiotics, anti-infection or anti-cancer agents97 which are in
very high demand due to antibiotic resistance.100–102 Recent advances in
peptide synthesis have increased the ease of cyclic peptide production
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and study98 and hence the stage is set for cyclic peptides to become a
valuable aspect of modern medicine.
Figure 4.1: Gramicidin S, the first medicinal cyclic peptide, was discovered
in 1944 and used to prevent infection in gunshot wounds.
The first step of cyclic peptide manufacture is to obtain the linear
peptide precursor, by inserting a fragment of DNA that codes for the
desired peptide into E. coli bacteria which then produce the peptide,
or by chemical synthesis. Both methods are capable of producing low
cost product on the scale of kilograms. Now that the linear precursor
has been produced it must be cyclized - the most difficult part of the
process.116–120;141;143
The three forms of cyclization are head to tail, where the C and N
terminals come together to form the ring, side chain to side chain where
two side chains join together (often via a disulphide bond) and head or
tail to side chain. This work focuses on head to head cyclization as this
is the approach taken by the experimental collaborators. There are two
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approaches to cyclising the linear peptide: via conventional chemical
synthesis or via enzymatic cyclization.
4.1.1 Conventional Synthesis
The linear peptide is anchored to an insoluble polystyrene bead. This
prevents the peptides reacting with each other as the insoluble bead
immobilises the peptide,116 preventing them from reacting with each
other rather than cyclising. This technique allows the necessary dilute
reaction conditions to be mimicked without compromising on yield. The
cyclization reaction step is carried out with a Palladium catalyst before
the product is cleaved from the support. In order to prevent a head
or tail to side chain cyclization a number of protecting groups (small
chemical motifs which attach to a group to stop it taking part in the
reaction) are added to the peptide and must be removed later.
The advantage of this method is that overall yield is high, as in-
termolecular reactions are prevented by the beads, and the protecting
groups ensure that only head to tail cyclisaion takes place. Purification
of the product is easy as the large size of the insoluble beads means
impurities can be rinsed away. This is a significant advantage of this
process as product purity is critical; impurities such as leftover solvent
and catalyst are major safety concerns which are heavily regulated.121
This method is limited by the ability of the linear precursor to
preorganise into a conformation where the N and C terminus are close
to each other so that the reaction can occur. This conformation is
thought of as the transition state for cyclization and its adoption by
the linear precursor is the limiting factor of conventional cyclic peptide
synthesis.116–120;141;143 For a peptide to change conformation there must
be rotation around the bonds in the backbone. Rotation around the
peptide bond (the bond between amino acid residues) is limited due to
it being a partial double bond caused by the resonance shown in figure
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4.2. The other two bonds can rotate but the accessible torsion angles
are limited due to interactions between the side chains.
All naturally occurring amino acids are in L stereochemistry hence
the peptide bond is in the trans conformation. For an all L peptide to
adopt a cyclic conformation large amounts of steric strain build up in the
backbone, because the trans conformations force the other two backbone
bonds to adopt unfavourable torsion angles far from their equilibrium
values.116 Many organisms which produce cyclic peptides overcome this
by including D amino acids into the sequence, inducing a turn in the
linear peptide which makes a cyclic conformation less disfavoured. This
is because the backbone torsion angles do not need to move as far from
their equilibrium values to complete the ring. D amino acids are intro-
duced in nature by changing the stereochemistry of L amino acids with
the enzyme L Amino Acid Oxidase. Unfortunately D amino acids are
expensive so some other method is needed for synthesis.123
Figure 4.2: resonance forms of the peptide bond lead to a bond order
greater than one which hinders rotation.
Another way to introduce cis peptide bonds into the precursor is
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to include the artificial amino acid Pseudoproline in the precursor. This
induces a turn in the peptide backbone as shown in figure 4.3. After
cyclization the pseudoproline is converted into Threonine. The peptide
termini can also be brought closer together by using a metal ion to
chelate to the peptide backbone, lowering the energy of the cyclization
transition state as the interactions with the metal holds the near cyclic
conformation in place, shown in figure 4.4.
Figure 4.3: addition of pseudoproline (red) in the linear precursor reduces
the steric strain of the cyclization transition state due to the turn in the
peptide backbone.




A wide range of organic catalysts can temporarily react with spe-
cific side chains to hold the peptide in a horseshoe conformation, re-
ducing the distance between the termini. See reference116 for details.
Despite all these methods of reducing the energy barrier to cyclization
the efficiency of conventional synthesis varies depending on the peptide
to be synthesised, there being some sequences for which no method is
successful.116;124
4.1.2 Enzymatic synthesis
Many cyclic peptides are found in nature125–128 where they are synthe-
sised without employing any of the methods described above. Instead
the linear peptides are produced by the ribosome and are then cyclized
by enzymes. One well studied enzyme is PatG, found in the cyanobac-
teria Prochloron. Prochloron lives in a symbiosis with the marine or-
ganism Lissoclinum patella A.K.A. the Indo-Pacific Sea Slime (figure
4.5). Prochloron bacteria produce a variety of cyclic peptides which
have shown anti cancer activity,125 the most famous being Patellamide
A (figure 4.6) which has anti cancer properties and was discovered in
1982.129
Figure 4.5: Lissoclinum patella or Indo-Pacific Sea Slime. The green colour-
ing comes from symbiotic cyanobacteria which produce anti cancer cyclic
peptides using the PatG enzyme. Author: Nick Hobgood. Reproduced
from Wikipedia Commons under the Creative Commons Attribution-Share
Alike 3.0 Unported licence. See htt ps://creativecommons.org/licenses/by-
sa/3.0/deed.en for licence certificate.
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Figure 4.6: Patellamide A, the most well known cyclic peptide produced
by Prochloron cyanobacteria.
PatG works by taking a linear peptide and catalysing the cycliza-
tion reaction. Before cyclization begins the linear precursor is sometimes
modified by other enzymes, a number of amino acids can be converted
into other heterocyclic groups. The linear substrate of n amino acids
(represented by X) can be written as Xn...X2X1AYDG where X1 must
be Proline. This is because the peptide bond between X1 and X2 must
be in the cis conformation for the enzyme to work, and Proline is the
only natural amino acid which makes the isomerism possible at room
temperature.
The AYDG section is a recognition tag which binds to the ac-
tive site of PatG, the cis geometry of the X2 − Pro bond allows the
peptide chain to stick out away from the body of the enzyme. If the
X1X2 bond were trans then a large steric clash between enzyme and
substrate would prevent binding. The necessary presence of a Proline
or some other modified amino acid which increases the probability of
a cis peptide bond occurring, is probably common to most enzymatic
cyclization reactions as Proline is found in most short cyclic peptides.130




Figure 4.7: simplified scheme of PatG cyclization.
In more detail, the steps of the reaction are as follows:
1) - The AYDG tag binds to the active site of PatG (figure 4.7 frame a).
2) - Cleavage of the AYDG tag and binding of the Proline terminal
oxygen to the Ser783 group on PatG (figure 4.7 frame b).
3) - The bound peptide adopts a conformation where the free N termi-
nus is close to the anchored Proline (figure 4.7 frame c). This is referred
to as the Pre Cyclization Conformation (PCC).
4) - Head to tail cyclization reaction.
5) - Release of cyclic product (figure 4.7 frame d).
If the peptide does not cyclize within a certain time after binding
then the AYDG tag will be cleaved via a spontaneous hydrolysis reaction
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and the peptide will be released in the linear form. This time limit is
not known and is currently under investigation. The structure of PatG
is shown in figure 4.8.
Figure 4.8: the PatG enzyme. The groups which form the active site and
bind to the AYDG tag are shown in yellow. The red structure has been
proposed as a plug which, after peptide binding, moves in to prevent water
from interfering with the head to tail cyclization reaction. The gaps in the
structure are due to sections of flexible linker which are not resolved by X-ray
crystallography. Structure taken from RCSP data bank (4AKS).
The mechanism shown in figure 4.7 represents the best current
knowledge of PatG cyclization,126 however the point at which the linear
substrate adopts the PCC has not been confirmed. It could occur before
binding (frame a figure 4.7), between binding and AYDG tag cleavage




It is also not known to what extent the enzyme assists the substrate
in adopting the PCC. It is possible that the enzyme mechanically folds
the substrate into the PCC after binding, or this step could be diffu-
sional with the enzyme waiting for the peptide to find a cyclic conforma-
tion. Also, it has not been confirmed whether the conformational search
to adopt the PCC, assisted or otherwise, is rate limiting or whether the
rate of cyclization depends on other steps such as binding, tag cleavage
or the final cyclization reaction. Another unresolved aspect of the cy-
clization mechanism is the role of the proposed hydrophobic plug, shown
in red on figure 4.8. It is thought that this structure could prevent wa-
ter from accessing the active site once the peptide is bound,126 as water
molecules would interfere with the head to tail cyclization reaction.
4.1.3 Objectives
The aims of this study are to use BXD to address the following:
1) - To Develop a method of predicting whether or not a sequence of
amino acid residues can be cyclized by the PatG enzyme.
2) - Make a high throughput in silico screening tool for designing medic-
inal cyclic peptides.
3) - Investigate the mechanism of PatG cyclization. Is the adoption of
the PCC diffusional or enzyme assisted, and is it the rate limiting step?
4) - Test the model on other enzymes to determine if the mechanism of
PatG cyclization is common to other enzymes.
5) - Find some general rules for what makes a peptide cyclisable.
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4.2 Existing Methods of Predicting Pep-
tide Cyclization
A major limitation of any method of cyclic peptide synthesis is the
lack of understanding of what factors affect the propensity of a linear
precursor to adopt a cyclic conformation, necessary for the reaction to
occur.141 Most computational studies on cyclic peptides focus on the
prediction of the structure of the cyclic product108–112 rather than the
probability that the linear precursor will cyclize. However some theo-
retical studies have been made and are discussed in the following.
In 1992 Cavelier-Frontin et. al. investigated the effect of the dif-
ferent ways of arranging the amino acids in the linear precursor.141
The cyclic tetrapeptide Chlamydocin consists of four amino acids Aib−
Phe − Pro − Ala, where Aib is aminoisobutyric acid which induces a
peptide to form alpha-helixes.142 Chlamydocin can be synthesised from
four linear peptides: Aib−Phe−Pro−Ala (A) Phe−Pro−Ala−Aib
(B), Pro−Ala−Aib−Phe (C) or Ala−Aib−Phe−Pro (D). Precursor
C is the only one that cyclizes.
The authors first investigated whether steric effects in the differ-
ent precursors hinder ring closure to different extents. This was done
by taking the experimental structure of each amino acid in the cyclic
product and using them to reconstruct the precursors A,B,C and D.
Single point energy calculations were then carried out for each of the
linear structures at close end to end distances to calculate the potential
energy of the cyclization transition state for each peptide. No signifi-
cant difference in these energies was found so the authors ruled out this
factor.
Cavelier-Frontin et. al. then used an energy minimisation on each
of the four transition states to find the relaxed structure for each linear
83
4.2 Existing Methods of Predicting Peptide Cyclization
peptide for which the potential energy was lowest. Single point calcula-
tions were carried out on these structures and the difference in energy
between them and the transition state was calculated and taken to be
the activation energy for cyclization. It was found that linear peptide
C, the only one which can cyclize, had the lowest activation energy.
After this successful trial the same method was extended to four other
four membered cyclic peptides and the correct precursor was identified
in each case.
Despite its success this method is limited due to the fact that it
does not consider the conformational space of the peptide. Only sin-
gle, static structures are taken for the transition and extended states of
the peptide and the cyclization reaction is assumed to be a function of
the difference in potential energy between these structures. This is a
static view of the system which is not suited to the dynamical nature of
biomolecules. Also the structures considered were generated by simple
energy minimisations which do not explore the complicated conforma-
tional space of the peptide; there is no way of knowing whether the
structure chosen as the extended conformation is in fact the global free
energy minimum or one of many local minima which exist in equilibrium.
While these limitations may not be critical for very short pep-
tides it is unlikely that this method could be extended to large systems
where the conformational space is larger and more complicated. This
was the case when Besser et. al.143 applied the above method to other
four membered cyclic peptides and found it to be unsuccessful. Despite
these shortcomings credit should be given for what was achieved at a
time when a more rigorous calculation or simulation would have been
very expensive.
In their work Besser et. al. assumed that the ability of a linear
sequence to cyclize depends on the probability of finding the system in
a cyclization transition state structure, that is with the termini close
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together. This was done by first generating an ensemble of possible
conformations of the linear peptide. For this a Monte Carlo Multiple
Minimisation (MCMM)131 method was used. A starting structure is
chosen and rotations of the peptide backbone bonds are introduced by
changing the angle of torsion of randomly selected bonds. An energy
minimisation is performed on the new structure which is then compared
to the previous step. Only the backbone bond angles were varied in or-
der to focus on the ’signal’ of peptide conformational change rather than
the ’noise’ of side chain fluctuations. If it is sufficiently different it is ac-
cepted and the angles are perturbed again and the process is repeated,
the new structures being compared to all the previous accepted ones.
Every time a structure is accepted it is added to an overall set of po-
tential energy minima. Besser et. al. used this process until they had
a large number of structures from which they selected the 300 that had
the lowest potential energy.
Each of these was then used as a seed in a separate MCMM cal-
culation until a very large number of conformations had been gathered.
MCMM generates an ensemble corresponding to a particular tempera-
ture which determines the magnitude of the torsion angle change, higher
temperatures lead to larger perturbations. The next step was to apply
MCMM method to starting structures where the ends of the peptide
were close together, representing a conformation from which the cy-
clization reaction could occur.
During the MMCM procedure some structures were constrained so
the ends of the peptide remained close together, resulting in an ensem-
ble of transition state structures. In order to estimate the probability
of a transition state occurring each of the structures in the unrestricted
ensemble were compared to the set of transition state structures. The
total number of structures from the ensemble which were found to be
close to a transition state structure was divided by the total number of
structures in the ensemble to give the probability of finding the peptide
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at the transition state. This is illustrated in figure 4.9.
This approximation of transition state probability relies on the
system being sampled ergodically so that a fair Boltzmann weighted
ensemble is produced. Because of this the MCMM run used to generate
an ensemble was continued for around 300000 steps.
Figure 4.9: the Monte Carlo Multiple Minimisation procedure used by
Bresser et. al.143 to generate an ensemble of conformations of a peptide.
The cyclization probability of five peptides calculated in this way
were compared to experimental data. At 300 K the coefficient of correla-
tion between theoretical and experimental data was only 0.59 implying
a poor performance of the model.143 By changing the temperature in
the MCMM procedure and generating a new ensemble of structures at
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1000 K the coefficient of correlation was improved to 0.92 and after the
temperature was again increased to 5000 K the coefficient fell to 0.78.
The authors attribute this effect to discrepancies in the force field used.
At all temperatures the most and least likely peptides to cyclize were
ranked correctly, the ordering of the others being incorrect. Despite this
seemingly low success rate the peptides which were furthest apart in cy-
clization probability correspond to a factor of 2 in the experimental rate
of cyclization. This limit on the accuracy of the method is quite good
considering that the rate constant for cyclization of peptides can vary
by a factor of 500.132 The authors also report that each conformational
search took around 4 hours143 on a cluster of 8 400 MHz processors,
which is a very short simulation time especially considering the very
modest processors used.
In a recent study of peptide cyclization133 Yongye et. al. used
conventional unbiased MD to investigate the cyclization ability of three
small peptides. After running 20 ns trajectories of each peptide they col-
lected the most common conformations that were sampled. To predict
which sequences would cyclize they compared the number of extended
conformations where the ends are far apart to the number of transition
state structures. This method is conceptually similar to that of Besser
et. al. the difference being MD was used to sample the conformational
space rather than MCMM. Two out of the three peptides are known
from experiment to cyclize readily.
The peptide which cyclizes best in experiment was found to have
well populated conformations where the ends of the peptide are held
close together by backbone hydrogen bonds, presumably making the
cyclization reaction more likely. The peptide which does not cyclize
was found to have well populated extended conformations where the
termini are far apart and few with the ends close together, making cy-
clization less likely.
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The authors reported that the third peptide provided inconclusive
results as the backbone was stiff,133 meaning that conformational sam-
pling was poor during the simulation due to the large energy barrier of
rotation of backbone bonds. This prevented meaningful results from be-
ing obtained as the conformational space must be well sampled for the
relative numbers of extended and transition state structures to match
the true Boltzmann ensemble.
BXD has previously been used to investigate peptide cyclization by
Shalashilin et. al. in 2012.94 The aim of this study was to reproduce the
findings of Volk and Hochstrasser134–136 who investigated the kinetics
of peptide cyclization. A cyclic peptide was produced with the ends
joined together by a sulphur bridge. Flash photolysis is used to break
this bond leaving a sulphur radical on each end of the peptide, bond
cleavage taking place on the sub picosecond timescale. The peptide
is then free to diffuse until the ends come together again and the two
radicals recombine to reform the sulphur bridge and cyclize the peptide
again. The presence of the radicals leads to a characteristic absorption
which is monitored over time and the rate at which the strength of
the absorption decreases is related to the rate of the cyclization of the
peptide. The procedure is shown in figure 4.10.
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Figure 4.10: monitoring the rate at which the absorption from the sulphur
radicals is quenched allows the rate constants for cyclization to be calculated.
Shalashilin et. al. used BXD to calculate the rate constants of
cyclization for the peptides studied by Volk et. al.134–136 The reaction
coordinate was defined as the distance between the two ends of the pep-
tide and boundaries were placed along it at distances of between 3 and
40 A˚. The phase space along the coordinate was sampled as the tra-
jectory diffused through the boxes (see figure 2.3) allowing box to box
rate constants to be determined (equation 2.6) which were then used to
calculate the free energy along the reaction coordinate (equations 2.6
to 2.8). The resolution of the rate constants was increased by using
the procedure described in reference94 (see equations 2.15 to 2.17) and
equations 2.9 to 2.11 were used to calculate the rate of cyclization.
In the experiments134–136 the cyclization of the peptide is irre-
versible as it involves the recombination of the sulphur radicals. To
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take this into account in the analysis of the BXD rate constants a tran-
sition state for cyclization is set at 5 A˚ and the rate constant for crossing
the boundary placed at 5 A˚ to higher extensions is set as zero, mim-
icking the irreversible nature of the radical recombination. The rate
constants for cyclization were estimated by calculating the population
of the box at 5 A˚ with respect to time and were in excellent agreement
with the experiments of Volk et. al.,134–136 matching the experimental
data over several orders of magnitude. Each peptide took a few CPU
days to converge.
No other literature on the prediction of peptide cyclization could
be found, and no studies could be found where cyclization was predicted
for the enzymatic route rather than for conventional synthesis. Given
that BXD has already successfully been applied to peptide cyclization
and is a proven way of overcoming the long timescale problem44 that
affected the work of Besser et. al.143 it was decided that BXD would be
used to undertake the blind test.
4.3 Method
4.3.1 The Blind Test
The Jaspars group at Aberdeen University are developing a method of
cyclic peptide synthesis which uses the PatG enzyme to cyclize linear
peptides into designer cyclic products, avoiding many of the limitations
of traditional cyclic peptide synthesis. The aim is to use a single enzyme
that can cyclize a general linear peptide which will lead to easier pro-
duction than conventional synthetic methods which have variable yields
depending on the sequence.116;124 Enzymatic cyclization also has the
advantage that no harmful catalysts or other reagents must be added
leading to a safer and cheaper production of APIs as purification and
quality control would be easier.
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Seeking to improve the efficiency of their enzymatic production
the Jaspars group presented a challenge: given a number of amino acid
sequences could we predict which ones would cyclize with their enzymes?
Two sets of sequences were given: one from PatG and one from an
enzyme from another species of cyanobacteria, AcyG. These peptides
that do cyclize were mixed in with other sequences which are known
from experiment not to cyclize. The experimental results of cylisation
were withheld until a prediction had been made. Thus the model and all
the various parameters would have to be developed in the dark - a blind
test. If the model were successful then this would aid the Jaspars group
design medicinal cyclic peptides as less time would be spent trying to
produce products which cannot be cyclized.
4.3.2 Predicting Cyclization with BXD
BXD was used to calculate the free energy of cyclization for the pep-
tide sequences provided by the Jaspars group. The reaction coordinate
chosen was the distance between the two ends of the peptide as it is
these termini which must come together to cyclize the substrate thus
this coordinate differentiates between cyclized and linear states, and the
free energy along it should correspond to the free energy of cyclization.
This is shown below in figure 4.11.




Boundaries were placed at intervals of between 1 and 2 A˚ along the
reaction coordinate and the number of collisions required to pass into
the next box was set at 1000. The boxes started at 3 A˚ and continue
upwards to a length at which the peptide is judged to be mainly linear.
This upper limit was produced empirically and was usually around 2.5 A˚
multiplied by the number of amino acids in the chain. This limit reflects
a compromise between effective sampling and simulation efficiency. If
the peptide does not extend to high enough free energies then the num-
ber of pathways sampled on the way down the reaction coordinate will
be limited, however if too much time is spent at high extensions then
the simulations will be slow.
For each peptide 20 trajectories were simulated with BXD, start-
ing from the linear conformation with a different initial distribution of
velocities. This ensures that the phase space is well sampled as there are
20 sets of initial conditions. Simulations were continued until the free
energy had converged for each peptide. Convergence was checked by
taking the data from each of the 20 trajectories and splitting it in half.
Each half dataset was used to calculate the free energy and this was
compared to the free energy calculated with all the data. If the two free
energies were similar then that trajectory was said to have converged,
and if not then more simulations were carried out until each peptide had
20 converged trajectories. Usually this occurred when a trajectory had
completed around 20 to 50 cycles in both directions (similar to those
shown in figure 2.4) through the reaction coordinate. The free energy
was then calculated for each of the 20 trajectories and then averaged.
The EEF1 implicit solvent model was used, as in Chapter 3 for the
AFM unfolding study. While the EEF1 model is not the most accurate
solvent model it is suitable for this application as it is very fast, which
is a requirement as 20 trajectories were simulated for each member of a
large set of peptides. The EEF1 model is very basic however this may be
more appropriate for this application as it is not known to what extent
the bound substrate is exposed to water, as the role of the hydrophobic
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plug (red structure in figure 4.8) has not been resolved hence a more
accurate solvent model may not be appropriate.
The set of sequences provided by the Jaspars group for AcyG and































The miscellaneous sequences were provided some weeks later as
more experimental data became available.
The following sequences were provided for PatG. Modified residues
are denoted by X and Y. Italic letters indicate D stereochemistry rather
than the usual L. The groupings of the sequences are arbitary and ar-


































DXYSKLQP (B25) X=Piperidine Y=Cbz





The modified residues are shown below in figure 4.12
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Figure 4.12: modified residues present in the PatG sequences.
The decorrelation procedure was used on the rate constants cal-
culated by BXD was done as described in section 2.1.1 by varying the
cuttoff τdecor until the free energy no longer changed. For all peptides
τdecor was found to be 120 fs. An example of the procedure is shown in
figure 4.13.
Figure 4.13: decorrelation of the free energy along end to end distance for
the peptide S7. A value of 50 fs was chosen as the decorrelation time as the
free energy no longer changed when it was increased any further.
4.4 Theory
The following assumptions are made about enzymatic cyclization:
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1) - The rate limiting step is the formation of the PCC by the substrate
(frame c figure 4.7).
2) - The formation of the PCC is diffusional: the peptide finds a cyclic
conformation through its own dynamics without assistance from the en-
zyme.
3) - The sequence of residues in the substrate is the only factor affecting
the rate at which the PCC is adopted.
These assumptions are made to simplify the model. Without as-
sumption 1 the chemical reactions of binding and cyclization would have
to be included which would necessitate the simulation of quantum dy-
namics and electronic structure. This would be prohibitively expensive
for any high throughput screening tool. Assumption 2 simplifies the
theory further by allowing the peptide to be simulated without the en-
zyme. This makes the simulations much cheaper. Assumption 3 allows
the model to be used for different systems as only the identity of the
substrate needs to be considered.




where kc is the overall rate constant of cyclization, P
6= is the probability
of the peptide adopting the PCC and the factor K, which is assumed
to be the same for all peptides, accounts for all the stages in figure
4.7 apart from formation of the PCC. The PCC is defined as when the
termini are 4 A˚ away from each other. Because of the assumptions made
in the model this probability is the only factor in equation 4.1 which












where the numerator is the Boltzmann factor for the box covering the
transition state at 4 A˚ and the denominator is the partition function for
all the boxes along the reaction coordinate. The assumption that only
P 6= varies between peptides is made to increase computational efficiency
as it means the peptides can be simulated in isolation. Fortunately this
simple treatment increases the usefulness of the study; if the model is
accurate and the free energy along the cyclization coordinate is enough
to predict enzymatic cyclization then the PatG enzyme only holds one
of the peptide and cyclization is diffusional. If the model fails to make
accurate predictions then the enzyme must do more to catalyse the
cyclization. The model will not only help design cyclisable sequences
but the it will illuminate the mechanism of PatG cyclization.
4.4.1 Asessing Model Performance
The model ranks the peptides in order of how likely they are to cyclize,
whereas the experimental data only states whether or not that sequence
can be cyclized with a binary yes or no. To compute the accuracy of
the model it is necessary to compare the same data; the ranking of
sequences must be converted into a yes/no prediction. To do this the
Jaspars group provided us with the relative numbers of peptides that
do and do not cyclize. Once this number is known the sequences are
ranked according to their value of P 6= calculated by BXD. If we know
the number N of peptide which do cyclize then the top N peptides in
the ranking are said to cyclize and the others are said not to. A direct




In general the set of 20 free energies for each peptide are well converged
with a standard deviation from the mean of around 1 kJmol−1. An
example of an average free energy with one standard deviation is shown
in figure 4.14.
Figure 4.14: example of average free energy showing average of 20 trajec-
tories plus or minus a standard deviation. Taken from the peptide S10 with
the EEF1 solvent model.
4.5.1 AcyG
For the AcyG dataset the free energies along the cyclization coordinate
are shown below in figures 4.15 to 4.20. The transition state at 4 A˚ is
shown by the grey line.
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Figure 4.15: Free energy along end to end distance for 8 membered pep-
tides.




Figure 4.17: Free energy along end to end distance for 12 membered pep-
tides.




Figure 4.19: Free energy along end to end distance for 20 membered pep-
tides.
Figure 4.20: Free energy along end to end distance for miscellaneous pep-
tides.
4.5.2 PatG
For the PatG dataset the calculations were carried out both with and
without the AYDG tag which is shown in figure 4.7. This was done to
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investigate whether the substrate adopts the PCC before or after the
AYDG tag is cle aved. Most of the PatG sequences are not yet converged
so the results presented here are preliminary. When the ADYG tag was
included the model performed very poorly and the results were random.
All the cyclization probabilities were ver y low, of the order of 0.00001.
With the AYDG tag removed the performance was better, the early
results are shown in table 4.2. The free energies along the cyclization
coordinate, with the AYDG tag removed, are shown below in figures
4.21 to 4.28.
Figure 4.21: Free energy along end to end distance for set A.
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Figure 4.22: Free energy along end to end distance for set B.
Figure 4.23: Free energy along end to end distance for set C.
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Figure 4.24: Free energy along end to end distance for set D.
Figure 4.25: Free energy along end to end distance for set E.
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Figure 4.26: Free energy along end to end distance for set F.
Figure 4.27: Free energy along end to end distance for set G.
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Figure 4.28: Free energy along end to end distance for set H.
For the Acy dataset most free energies have a minimum at aroun
15 A˚. This is probably due to the fact that at a medium end to end
distance the peptide backbone angles are more favourable and result in
less torsion strain than at longer or shorter extensions. For the PatG
dataset the free energies of the sequences that do cyclize show a well at
much shorter extensions, this could be because of the inclusion of ar-
tificial and heterocyclic amino acids such as ThH, which induce a turn
in the peptide backbone and reduce the energetic cost of bringing the
termini close together. An example of this is the AcyG sequence S7,
which unlike mose AcyG sequences, contains several proline residues.
The results of applying equation 4.2 to the free energies shown
above are shown below in tables 4.1 and 4.2 for the AcyG and PatG
datasets respectivly. The sequences are ranked according to their val-
ues of P 6=. If N peptides are known to cyclize then the top N in the
ranking are predicted as ’yes’ by BXD. This prediction is compared to
the experimental result to assess if the model was correct.
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Table 4.1: results of the Blind Test for AcyG. The number of sequences
which cyclize was known to be 12. The accuracy here is 15 out of 21 or 71
%. The experimental result column shows a yes/no answer to whether the
data provided by the Jaspars group shows the peptide to cyclize.
Peptide P 6= Rank Prediction Experimental result BXD correct?
10b 0.067 1 yes yes yes
S7 0.042 2 yes yes yes
8d 0.033 3 yes yes yes
12b 0.024 4 yes yes yes
15d 0.023 5 yes yes yes
8b 0.022 6 yes yes yes
12d 0.018 7 yes no no
10c 0.017 8 yes yes yes
15b 0.007 9 yes no no
15c 0.006 10 yes no no
10a 0.005 11 yes yes yes
20b 0.002 12 yes yes yes
10d 0.002 13 no no yes
12a 0.002 14 no yes no
15a 0.001 15 no yes no
S15 0.001 16 no no yes
8a 0.001 17 no yes no
8c 0.001 18 no no yes
S10 0.001 19 no no yes
20a 0.001 20 no no yes
12c 0.000 21 no no yes
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Table 4.2: results of the Blind Test for PatG. The number of sequences
which cyclize was known to be 11. The accuracy here is 23 out of 29 or 79
%.
Peptide P 6= Rank Prediction Experimental result BXD correct?
B13 0.849 1 yes yes yes
B11 0.838 2 yes yes yes
B12 0.583 3 yes yes yes
B18 0.554 4 yes yes yes
B14 0.338 5 yes yes yes
B8 0.191 6 yes yes yes
B4 0.126 7 yes yes yes
B7 0.092 8 no yes no
B9 0.090 9 yes yes yes
B17 0.083 10 no yes no
B1 0.074 11 yes yes yes
B27 0.024 12 no no no
B3 0.019 13 yes no no
B10 0.019 14 no no yes
B15 0.013 15 no no yes
B5 0.008 16 yes no no
B6 0.005 17 no no yes
B2 0.002 18 no no yes
B28 0.001 19 no no yes
B16 0.000 20 no no yes
B25 0.000 21 no no yes
B26 0.000 22 yes no no
B20 0.000 23 no no yes
B23 0.000 24 no no yes
B29 0.000 25 no no yes
B24 0.000 26 no no yes
B21 0.000 27 no no yes
B22 0.000 28 no no yes
B19 0.000 29 no no yes
4.6 Discussion
Across both datasets BXD correctly predicted the cyclization of 38 out
of 50 peptides, achieving an accuracy of 76 percent. If the model was
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random and guessed yes or no then the chance of correctly guessing 38
out of 50 would be 0.0002 %. There is a strong correlation between
the free energy along the cyclization coordinate and the ability of the
enzyme to cyclize the peptide which suggests that the rate limiting step
of cyclization is the peptide adopting the PCC. This suggests that the
enzyme does not actively bring the ends of the peptide together, rather
it waits for cyclization to happen diffusively.
This result supports the assumptions made in equation 4.1 that
only the rate at which the peptide adopts the PCC varied from sequence
to sequence, the binding, cleavage and release steps143 happening at ap-
proximately the same rate between sequences. When the AYDG tag
was added to the simulation the model performed very poorly. Perfor-
mance improved dramatically when the tag was removed. This strongly
implies that the sequence of events proposed in figure 4.7 is correct, i.e.
the AYDG tag is cleaved before the peptide adopts a cyclic conforma-
tion.
It should be noted that the cyclization probabilities for AcyG are
all low. Besser et. al. report cyclization probabilities of between 0.1
and 0.6 for several peptides. This difference is probably due to the fact
that the peptides studied here are all L sequences with no turn inducing
residues in the backbone. For the PatG dataset the probabilities of cy-
clization are much higher, in the range given by Besser et. al.. The PatG
sequences contain many Proline residues and heterocycles which are not
present in the AcyG dataset. Hence the higher cyclization probabilities
of the PatG sequences is concurrent with the theory that heterocycles




4.6.1 Factors Affecting Cyclization
What factors affect the ability of a cyclic peptide to cyclize? Although
all the discussion in the literature focuses on what makes a peptide cy-
clize in traditional non enzymatic synthesis the conclusions might still
be valid for the case of enzymatic cyclization, as the blind test above
concluded that cyclization probability correlates with the properties of
the independent precursor peptide. In this section the results of the
BXD simulations will be checked against the conclusions drawn in the
literature. This analysis will only be performed with the structures in
the AcyG dataset as the literature studies focus on peptides comprised
of the naturally occuring amino acids..
Some studies116;137 report that chain length is a factor; longer se-
quences are easier to cyclize because the total flexibility is higher and
the termini can come close together without creating as much strain
in the backbone. To see whether or not this is the case for the pep-
tides studies here a plot of cyclization probability against chain length
is shown in figure 4.29.




It is clear from figure 4.29 that there is no correlation between
chain length and cyclization probability. While longer peptides are in-
deed more flexible this might not have as large an effect as expected as
a longer peptide will have more conformational space to search before
it arrives at the cyclization transition state. This is equivalent to an
entropy penalty (transition states are less likely to be found as over-
all phase space volume is higher) offsetting the enthalpy bonus of the
torsion angles in the backbone being more favourable in the transition
state.
Yongye et. al. found that hydrogen bonding between the peptide
termini in the transition state lowered its energy and made cyclization
more likely.133 The occupancy of each hydrogen bond was calculated,
that is the fraction of trajectory frames for which the hydrogen bond was
present. This occupancy was found to correlate with the experimental
rate of cyclization. To investigate whether or not this is the case here
the trajectories from the BXD simulations were analysed. The struc-
tures of the cyclization transition states for peptides that were correctly
predicted are shown below in figure 4.30 for those that do cyclize, and
by figure 4.31 for those that do not. Structures were calculated by
taking all the trajectory frames for which the termini were 4 A˚ apart
and averaging them. Side chains were not included in the calculation
of the average and are not shown in the diagrams because their mo-
tion is fast compared to backbone movement which is more important
for conformational change. Clustering analysis was performed to check
the multiplicity of conformations at the transition state. For all the
trajectories one transition state conformation was present much more
frequently than any other, this conformation was used to calculate the
average. Hydrogen bonds are shown by purple lines.
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Figure 4.31: transition state structures of peptides that were correctly
predicted to cyclize.
Hydrogen bonds were defined as existing when the donor and ac-
ceptor atoms are within 3 A˚ of each other, and form an angle of less
than 20 degrees with the proton, which is consistent with the accepted
definition in the literature.138 The occupancy of each hydrogen bond
was calculated as the fraction of frames corresponding to a transition
state in which the bond was present, rather than over the whole trajec-
tory as was done by Yongye et. al. This was done because Yongye et.
al. used unconstrained MD simulations where the ensemble of confor-
mations reflected the true Boltzmann weighted ensemble, with a BXD
simulation the trajectory spends more time in high energy regions so
114
4.6 Discussion
hydrogen bond occupancy averaged over the whole trajectory is not
meaningful. Figure 4.32 shows the calculated cyclization probability
against the occupancy of the inter terminal hydrogen bond.
Figure 4.32: cyclization probability against occupancy of inter terminal
hydrogen bond.
It is clear from figure 4.32 that there is no correlation between
the strength of the inter terminal hydrogen bond and the cyclization
probability. In their study of the cyclization rates of a large library of
linear peptides137 Thakkar et. al. reported that peptides with large
side chains on their C termini cyclize less readily. Figure 4.33 shows




Figure 4.33: cyclization probability against molar volume of side chain on
C terminus. Volumetric data taken from reference139.
Again there is no real correlation between the molar volume of the
C terminal side chain and the cyclization probability. It might be said
with caution that amino acids with the largest side chains should not be
placed on the C terminus of the linear precursor but there are only three
data points for these larger side chains. However it is plausible that the
steric bulk of these side chains prevents the terminal carbon and nitro-
gen atoms from coming within reactive range of each other. Thakkar
et. al. also report that many of the sequences that do not cyclize are
rich in Lys, Arg and Thr or contain the motifs ArgArg, LysLys, ArgLys,
LysArg, ThrThr, ThrLys or LysThr. This correlation is not present in
the sequences studied here; the sequences alone give no hint of whether
or not they will cyclize.
Cavelier-Frontin et. al. examined the values of the backbone angles
in the transition states of the peptides they studied. The distribution
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of the backbone angles Ψ and Φ (see figure 4.34) is often plotted in a
Ramachandran plot (see figure 4.35).
Figure 4.34: the angles used to create Ramachandran space. The third
angle ω is not included as it is usually close to 180 degrees due to its partial
double bond character.
Figure 4.35: the allowed regions of Ramachandran space. Blue areas are
highly favoured and green areas moderately so. Certain regions correspond
to alpha helices or beta sheets.
Each amino acid residue contributes one point to the Ramachan-
dran plot. Certain areas of Ramachandran space correspond to beta
sheets or alpha helices. The Ramachandran plots of the transition states
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of the peptides which were correctly predicted to cyclize are shown in
figure 4.36 and in figure 4.37 for those that were correctly predicted not
to.




Figure 4.37: Ramachandran plots for peptides correctly predicted not to
cyclize.
Cavelier-Frontin et. al. noticed that the peptide that cyclized most
readily had a transition state which featured backbone angles that oc-
cupied the centre of the Ramachandran plot. Inspection of figures 4.36
and 4.37 shows that this is not the case in this study; there appears to
be no link between the cyclization probability of a peptide and the Ra-
machandran plot of its cyclization transition state; the transition state
Ramachandran plots of sequences that do and do not cyclize are very
similar.
In a 2013 study140 Diadone et. al. showed that the cyclization abil-
ity of peptides depended on the structure of the extended conformation.
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Peptides that cyclize more readily were found to have Hydrogen bonds
that stabilised a turn in the lowest free energy open conformation, mak-
ing cyclization easier. This conclusion was drawn for larger peptides of
around 20 or more amino acids which consisted of repeating GlySer
units. To see if this conclusion can be carried over to shorter peptides
containing different amino acids the lowest free energy, or extended,
structures of the peptides are shown in figures 4.38 and 4.39.




Figure 4.39: extended structures of peptides that were correctly predicted
not to cyclize.
Figures 4.38 and 4.39 show that there is no correlation between
the probability of cyclization and hydrogen bond stabilised turns in the
extended conformation. Peptides 10c, 15b and 15c show this character-
istic but they are poor to middling in terms of cyclization.
After having examined the results of this study in light of the con-
clusions drawn in the literature it seems that we have not yet been able
to find any rule of thumb to explain the different rates of cyclization.
Rather than inspecting the transition states and extended structures it
is necessary to extensively sample the conformational space of a peptide
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to predict its cyclization probability. No simple dependence on sequence
could be made out from this dataset however this is not a problem as
the calculations are cheap (roughly one CPU day per peptide per tra-
jectory) hence high volume in silico screening is possible.
The performance of the model was good given its simplicity in
modelling only the peptide diffusion rather than including any of the
enzyme of the chemical reactions. Given the models simple implementa-
tion with a cheap solvent model and the presence of the substrate only,
an accuracy of over 75 percent can be seen as a success. The incorrect
predictions could be due to limitations in the assumption that the only
factor affecting cyclization probability is the ability of the linear precur-
sor to adopt a cyclic conformation and that the enzymes play no active
role in assisting this. Despite this it seems that these assumptions are
mostly correct.
The inaccuracy in the model could also come from the parameter
chosen for the distance between the ends of the peptide at the transition
state. The 4 A˚ transition state distance is close to that used in the
literature141;143 of around 3 A˚, however it is much harder to sample the
conformational space at a separation of 3 A˚ than at 4 A˚ due to the
much increased free energy at closer distances. The extra Angstrom
of separation should not make much difference as the transition state
found by a classical forcefield cannot accurately reflect that of a real




The work presented in this chapter can be summarised as follows:
1) - BXD can accurately predict whether or not a given sequence can be
cyclized by the Acy or PatG enzyme. The model achieved an accuracy
of 76 %.
2) - The rate limiting step of enzymatic cyclization with PatG and AcyG
is the substrate peptides conformational search to adopt a cyclic confor-
mation (PCC).
3) - The peptide is not assisted by the enzyme while it adopts the PCC,
it is a diffusional process.
4) - Cleavage of the AYDG tag occurs after the peptide is bound to the
enzyme and before the PCC is adopted.
5) - The rates of binding, AYDG cleavage and product release do not
vary significantly between substrates.
6) - Based on analysis of the AcyG dataset there is no simple rule of
thumb has been found to predict whether or not a sequence can be cy-
clized.
7) - Predictions were made quickly and cheaply, each trajectory con-
verged in between 1 and 5 CPU days.
4.8 Further Work
Further work will focus on making predictions for more sequences and
for different enzymes in order to increase the scope of the model and
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test the validity of its assumptions on more systems. The insights about
the mechanism of cyclization are not obtained directly and are some-
what speculative. More sophisticated BXD simulations, including the
enzyme or other stages of cyclization, could be undertaken to carefully
check the conclusions drawn here.
We are also working with experimentalists who are now trying to
measure the rates of PatG cyclization rather than providing a simple
yes/no answer. This will allow direct comparison of the BXD results
with the experimental rankings as the experimental data will consist of
a list of peptides ranked in order of their rates of cyclization.
124
Chapter 5
Conclusion and Further Work
BXD has been shown to be a useful tool for efficient simulation of long
timescale processes. Insights have been into the mechanical unfolding
of proteins, using what we believe to be the first all atom simulation
of AFM protein pulling without the use of high artificial pulling forces.
BXD has been shown to be a very powerful tool, as experimental data
was accurately reproduced for the VC experiments and insights were
gained into the mechanical unfolding of three protein domains. All this
was done with trajectories that ran on a single CPU core for between
one and two weeks. Accurately simulating a biomolecular process which
occurs over a time scale of miliseconds to seconds would usually require
specially built supercomputers, convoluted algorithms or very large ad-
ditional forces.
BXD has also been used to build a fast and accurate in silico
screening tool for the production of medicinal cyclic peptides, as well
as to shed light on the mechanism of enzyatic peptide cyclisation. This
shows that BXD can be applied to areas of real world importance such
as the search for novel antibiotics. Because of the high speed at which
calculations converge, roughly two days on a single core, and the fact
that the high accuracy was maintained accross a dataset of 50 sequences,
the BXD screening tool presented here is applicable to the pharmaceu-
tical industry where very large libraries of candidates must be checked.
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BXD is a novel technique in that, for these applications, both ki-
netic and thermodynamic information is provided quickly and on mod-
est hardware, without the need for powerful computers or convoluted
biasing routines or modification of the potential energy landscape. Fur-
ther work will focus on the following three areas:
1) - AFM protein pulling will be simulated with concatamers rather
than individual domains, and explicit water will be used.
2) - Simulation of peptide cyclisation will continue with more datasets
from different enzymes.
3) - BXD will be added to other MD packages such as GROMACS in
order to benafit from GPU acceleration.
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Appendix A
Worked Example of Free
Energy Calculation
This chapter gives a detailed account of how to calculate free energy
using BXD. The example chosen is the small peptide B11 (see Chapter
4) with end to end distance as a reaction coordinate. For the input
files and other analysis scripts used in BXD contact the author at jj-
booth1989@yahoo.com. Many of the processes outlined here are close
to being automated so for future studies BXD will be much faster and
easier to carry out.
A.1 Box Placing
Placing the boundaries along the reaction coordinate (see Chapter 2) is
a balance between computational efficiency and the quality of the sam-
pling. If the boxes are too large then the simulation will be slow as the
trajectory will still have to travel to higher regions of free energy with-
out assistance from the ratched effect of the boundaries. If the boxes are
too small then the kinetics and thermodynamics obtained will not be
valid as the trajectory will not relax between collisions and the decor-
relation proceedure, which ensure that the mathematical foundation of
BXD is valid, will not work. In general it is best to make the boxes as
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large as possible without sacrificing the speedup provided by BXD.
To determine the best arrangement of boundaries, a quick BXD run
is carried out where the boxes are spaced widely apart. The number of
collisions required to pass into the next box is set to a very low num-
ber such as 5 in order to quickly determine the optimimum boundary
locations. If the trajectory does not quickly cycle through the reaction
coordinate then the boxes are too large, as anything other than a fast
cycle time will increase to a much slower time when the numbner of
collisions requiured is increased from 5 to a much larger number for the
production run.
In this example, initial boundaries were placed at intervals of 1 A˚,
from 4 A˚ to 26 A˚, with 5 collisions required to pass into the next box.
These boundaries were too widely spaced as a trace of the reaction co-
ordinate against simulation time (figure A.1) shows that the trajectory
stalls and does not quickly complete a cycle of the reaction coordinate.
Figure A.1: In this box placing BXD run the boundaries (red lines) are too
far apart resulting in a stalled simulation, as the trajectory (black line) does
not leave the upper box.
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The box sizes are reduced in areas where the trajectory stalls and
the box placing runs are repeated until the trajectory can cycle through
the reaction coordinate quickly. In this case the final boundries went in
intervals of 0.5 A˚ from 3.5 A˚ to 6 A˚, and from 22 A˚ to 26 A˚, with the
region in between 6 A˚ and 22 A˚ having boundaries at intervals of 1 A˚.
In general the regions of denser boundaries represent areas of steeper
free energy where the trajectory requires more assistance. The trace of
reaction coordinate against time for the final satisfactory arrangement
of boundaries is shown below in figure A.2.
Figure A.2: a good distribution of boundaries allows the reaction coordinate
to be sampled efficiently.
Care must be taken not to make the boxes too small, which would
prevent the decorelation proceedure (see Chapter 2) from working and
undermine the results provided by BXD. To check if this is the case the
trajectory can be inspected to see how frequently it collides with the
boundaries of each box. Figure A.3 shows an example where the boxes
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are far enough apart for decorelation to be successful and where they
are so close together that the trajectory rattles between the boundaries
without any ergodic sampling of the phase space within the box.
Figure A.3: if a box is too small (left) then the trajectory hits the bound-
aries (red) too frequently and cannot equilibrate within the box. Decorrela-
tion here is impossible as there are no FPTs longer than the characteristic
decorrelation time. If the box is large enough (right) then decorrelation is
possible as the trajectory can explore the box and come to equilibrium in
between collisions with the boundary.
Once an efficient distribution of boundaries has been found the
number of collisions should be increased from 5 to around 1000 for the
production run. As of 2016 this proceedure has been fully automated
by the Glowacki group in Bristol and boundaries are adjusted on the fly
to optimise the efficiency of the simulations.
A.2 Collision Threshold
The number of collions required to pass from one box to the next must
be high enough for the trajectory to equillibriate and sample each box
well, but not so high that the trajectory spends too long in each box
and does not cycle through the reaction coordinate many times, which
would limit the range of different pathways that the trajectory samples.
130
A.2 Collision Threshold
The ideal value for this parameter has been empirically determined to
be around 1000.
A.2.1 Decorrelation
Once the boundaries have been placed and a production run is under-
way the decorrelation time for the system needs to be found. After the
trajectory has completed around 20 cycles through the reaction coordi-
nate the free energy is calculated with a decorelation time of 0 fs. The
free energy is calculated again with an increased decorelation time until
it no longer changes. The decorelation time τ at which the free energy
has converged is taken as the decorelation time of the system and is used
to calculate the final free energy of the production run. This process is
illustrated below in figure A.4 for the peptide used in this example. For
a theoretical description of decorelation see Chapter 2.
Figure A.4: the free energy is calculated at different decorrelation times
until it no longer changes. The time τ at which the free energy no longer





To check whether a simulation has converged, while a production run
is still progressing the free energy is calculated after a certain time has
passed, usually one day, and again after double that period. If there is
no significant change between the two free energies then that trajectory
is said to be converged. If the free energy has not yet converged then
the test is repeated at longer time intervals until convergence is reached.
Figure A.5 shown an example of a free energy which has converged and
one which has not.
Figure A.5: to test for convergence the free energy is calculated after 1
day and again after 2 days. If the free energy changes significantly (top
frame) then it has not converged and the calculations continue, the conver-
gence check being repeated at intervals of 2 days and 4 days.. If there is no
significant chnge (bottom) then the free energy has converged.
Note that the procedure described above is for a single trajec-
tory. To better sample the phase space multiple independent trajecto-
ries should be generated and their individual free energies calculated in
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the above way, until they have all converged and are then averaged.
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